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Summary of Main Findings 
The findings from this study refer to treated drug misuse and are based on information from a 
reporting system on clients who received treatment for their problem drug taking in 1990, and 
who resided in the greater Dublin area. Treatment was provided by a range of statutory and 
voluntary treatment centres considered representative of drug treatment availability in the 
catchment area. 
The main findings were: 
− An estimate of 1752 persons received treatment for drug misuse in 1990; 
− The estimated number who entered treatment for the first time ever was 574; 
− Seventy four percent of clients were male; 
− Most clients, 95%, were between 15 and 39 years old; 
− Half lived with their family of origin; 
− One third resided in the inner city area; 
− Forty four percent had left school before the official school leaving age of 15, women 
proportionally more so than men; 
− Eight out of ten clients were unemployed; 
− In 80% of cases an opiate was the primary drug of misuse, chiefly heroin; 
− The majority, 68%, had injected their primary drug; 
− Slightly more than half the study population had been misusing their primary drug for five 
or more years; 
− Of those who had ever injected their drugs 65% were currently injecting, but only 17% 
were currently sharing, and 
− Proportionally more women than men were living with a drug misusing partner, and also 
more women than expected were sharing injecting equipment. 
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CHAPTER 1 
Introduction and Background 
1.1 Introduction 
In September 1968 the Irish Press published a series of articles on drug abuse in Ireland. 
It was the first time the media had focused on the problem or that anyone had even 
suggested there was one (Flynn and Yeates, 1985:5). 
Now more than two decades later drugs and their misuse have become a major concern for 
the Government, who recently produced a “Strategy to Prevent Drug Misuse” and for 
parents, schools, service providers and above all for problem drug users, many of whom 
also have to deal with the spectre of HIV or AIDS. 
 The purpose of this report is to document the extent of treated drug misuse among 
residents in the greater Dublin area in 1990, and to provide basic information on the socio- 
demographic profile of drug misusers, and on their injecting and sharing practices. A 
reporting system is the method used to collect the data. 
 For years now wide ranging estimates have been made of the number of drug users 
in Dublin usually without any defining statement of whether they refer to ‘treated drug 
users’, ‘all drug users’, those ‘in contact with treatment services during a given year’ or ‘at 
a given point in time’. This paper provides a first attempt at identifying cases of treated 
drug misuse and the number of persons involved as a person may be attending more than 
one treatment centre thus introducing an element of double count. There are some gaps in 
the information presented mainly relating to general practitioners, but coverage on the 
whole is good and very representative of the range of treatment services, statutory, 
voluntary, medical and non-medical in the catchment area. 
 Ongoing information from this reporting system will facilitate an understanding of 
the epidemiology of treated drug misuse, and provide useful data to policy makers on its 
social and health care implications. Access to the database will be available to bona fide 
researchers. It will also be a data source for the participating centres in providing access to 
their own data on an annual basis and to reasonable requests for other data. 
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1.2 History of Drug Misuse in Dublin 
As noted in the Introduction the alleged first media reference to problem drug use in 
Dublin was made in 1968. In December of that year the then Minister of Health set up a 
Working Party to establish the extent of drug misuse in the country. This was largely 
prompted by public disquiet at the increasing evidence of drug misuse in their capital city. 
The Working Party’s interim report of November 1969 documented a significant drug 
problem in Dublin with 350 regular users known to the Gardai. The drugs involved were 
predominantly amphetamines, barbiturates and tranquillisers, usually obtained by larceny, 
in addition to LSD and cannabis smuggled into the country. 
 The recommendations of this interim report (a summary of which is contained in the 
final report) urged that action should be taken forthwith to update legislation; to improve 
security in pharmacies and manufacturing wholesalers to minimise theft; to strengthen the 
Garda Drug Squad; to prevent doctors from overprescribing addictive drugs; to develop an 
out-patient facility for drug users in Jervis Street Hospital and to disseminate informed, as 
distinct from sensational, information on drug abuse. 
 The final report of this Working Party recorded an increase in the number of known 
drug users to 940 from 350 in 1969, (Report of the Working Party on Drug Abuse, 1971). 
Its recommendations covered statutory controls and other preventive measures, including 
one concerning the availability of hypodermic syringes, which stated ironically (p. 23) in 
the light of subsequent events 
we are fortunate in this country that heroin and other drugs normally administered 
intravenously are not abused to any significant extent. 
Action on the overprescribing of drugs and on the registration of persons dependent on 
drugs was proposed, in addition to recommendations on education, treatment and 
rehabilitation. 
 The reports of the Working Party established a benchmark of the first wave of drug 
misuse in Dublin – elsewhere in the country it was not seen as presenting a significant 
problem. The ensuing recommendations which were adopted created structures for 
prevention and treatment, for example: the strengthening of the Garda Drug Squad; The 
Medical Preparations (Control of Amphetamines) Regulations, 1969, which imposed rigid 
controls over the manufacture, importation and sale of amphetamines; the establishment of 
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a statutory outpatient treatment facility, the National Drug Advisory and Treatment Centre, 
and the introduction of rehabilitation services by Coolemine, a voluntary organisation. 
 However, the Misuse of Drugs Bill presented to the Dail in 1973 and introduced in 
1977, was not in force until 1979 by which time the problem had taken root. This new Act 
marked a watershed in drugs legislation by recognising the criminal dimension of drug- 
related crime and it was subsequently used to try some of Ireland’s well known drug 
dealers. Likewise there was a considerable delay in the implementation of drug education 
programmes. The proposed registration of addicts, as carried out by the British Home 
Office, was never introduced here and the problem of medical overprescribing is still with 
us. 
 Heroin hit Dublin’s north inner city area in 1981 well over a year after it had gripped 
the southside communities, and in a matter of a few weeks it had devastated the area 
(Flynn and Yeates, 1985 : 155). Reports of heroin misuse by youngsters, some still in 
primary school, were viewed with scepticism. In general there was considerable resistance 
to accepting how rampant the drug problem had become in the inner city area and how 
widespread was the fear of pushers in the community. 
 The report of the Eastern Health Board Task Force (1982) included evidence from 
sources, such as the National Drug Advisory and Treatment Centre, Coolemine 
Therapeutic Community, the Garda Drug Squad, general practitioners, and accident and 
emergency hospital departments which confirmed a sudden and dramatic rise in the 
number of young people misusing drugs, predominantly opiates. In response to this 
evidence the government established an Inter-ministerial Task Force (1983) to examine the 
question of drug misuse with special reference to the inner city area. 
 Directly arising out of their recommendations, made later in the same year, the 
following measures were introduced: 
− the Misuse of Drugs Act 1984 (which extended and amended the ‘Principal Act’ of 
1977) came into operation; 
− the Criminal Justice Bill 1983 was drawn up; 
− ‘life skills’ programmes were introduced in a number of schools; 
− a Diploma course in Addiction Studies in Trinity College, Dublin, was established; 
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− funding was provided to the Medico-Social Research Board to carry out drug 
research and 
− a National Co-ordinating Committee on Drug Abuse was set up to advise the 
Government on an ongoing basis on general issues regarding prevention and 
treatment of drug misuse. 
This sudden increase in the misuse of opiates by a young population in Dublin in the 
early 1980s was mirrored in most other European countries, the exception being that 
the onset was later in Dublin. Again, in common with these cities, the extent of 
serious drug use stabilised at a lower level until 1990 when indications of certain 
changes emerged. 
 There is increasing concern in Europe with the rapid change in patterns of drug use. 
The consequent need for effective action by each member state, supported by joint action 
by the twelve, has been voiced by the EC. The idea of setting up a European Drugs 
Monitoring Centre dates from 1989 and a European Committee to Combat Drugs 
(CELAD) composed of representatives of the twelve member states and the Commission 
was set up later in the same year to undertake the work, which is still ongoing. 
 As part of its role in developing an appropriate drug demand reduction programme 
the Irish Government re-constituted and strengthened the National Co-ordinating 
Committee on Drug Misuse in 1990 which was charged with the reponsibility of 
developing a policy to prevent drug misuse. Its report was adopted to become the 
Government Strategy to Prevent Drug Misuse (1991). 
1.3 Role of the Pompidou Group in Collaborative Drug Research 
The background to the collection of treatment data described in this report is grounded in 
the epidemiology work of the Pompidou Group, Council of Europe. This group was 
formed in 1971 following a proposal by Georges Pompidou, the then President of the 
French Republic, to his colleagues in the European Community and to the head of state of 
the United Kingdom. The aim of the group was defined as an examination, from a multi-
disciplinary point of view of the problems of drug abuse and illicit trafficking. Since 1980 
it has continued its activities within the framework of the Council of Europe, while 
remaining open for countries who are not members of the Council. An epidemiological 
sub-group was set up by the 6th Ministerial Conference in November 1981. The current 
work within this section is embodied in the decision made at that conference for 
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the development of administrative monitoring systems for the assessment of public 
health and social problems related to drug abuse. 
Administrative monitoring systems are now in place in 13 European cities including 
Dublin. These systems are based on information from a range of indicators of drug activity 
such as, first treatment demand; hospital admissions; viral hepatitis; drug-related deaths; 
persons charged for drug offences; imprisonment; seizures of illicit drugs; price/purity of 
illicit drugs; survey data and drug-related AIDS cases. Data derived from these indicators 
are put in the context of each country’s differing cultural, legal and health care provisions 
for drug misusers. These systems provide interpretations of drug misuse in the various 
participating cities and offer informed insight into similarities and differences between 
them. Analysis of information from the first multi-city study comprising Amsterdam, 
Dublin, Hamburg, London, Paris, Rome and Stockholm was published by the Council of 
Europe (1987). The co-ordination of data from the expanded multi- city study covering the 
period 1980-1991 inclusive, is currently taking place and publication, again by the Council 
of Europe, is expected shortly. 
 The future inclusion of material from Eastern European countries is planned as 
recently three countries have joined the Pompidou Group. 
 Some indicators are better developed than others e.g., first treatment demand, which 
will be referred to later in this chapter, while others such as drug-related deaths have 
emerged as unreliable both within cities and between cities. Efforts are ongoing to tease 
out what specific information relating to a particular indicator is available in each city and 
how these data can be made more comparable. The EC has recently made funding 
available to the 12 member states to examine the process by which drug-related deaths are 
ascertained in each country, highlight problem areas and on the basis of this analysis 
propose ways by which more accurate data can be derived. 
 New indicators have been proposed for development, such as, non-fatal urgent 
admissions to hospital for drug misuse and police arrests, and protocols have already been 
developed for discussion purposes. 
 It is important to note here that information from one indicator is never sufficient to 
indicate trends in drug misuse and can in fact be misleading. Analysis of drug misuse must 
include data from as many indicators as possible and, as earlier mentioned, supplement this 
source by information on the legal and socio-cultural context of drug taking. Recent 
proposals have focussed on the importance of getting some measure of the ‘hidden’ 
population of drug users not manifest by the indicator approach. Such proposals include 
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the desirability of carrying out a household survey of the general population, conducting 
ethnographic studies and improving methods of estimating the total number of drug users. 
 The work of the Pompidou Group is continually guided by directives from 
ministerial conferences and monitored by the permanent correspondents, usually senior 
civil servants, appointed by each of the participating member states to ensure the 
implementation of the work programme established by the ministers. The Pompidou Group 
maintains close contacts with other intergovernmental and non-governmental organisations 
concerned with problem drug use. 
1.4 Pilot Drug Treatment Reporting System in Dublin and London 
This project was undertaken and part funded as a direct consequence of the European 
Commission’s current policy on the fight against drug misuse. As already noted the 
increase in recent times in the availability and consumption of drugs in Europe has evoked 
a response from international bodies like the EC. 
 The broad objectives of the study were to develop further the first treatment demand 
indicator – seen as one of the best indications of treated drug misuse – and to explore the 
feasibility of establishing a reporting system on the socio-demographic characteristics of 
drug users in defined catchment areas. The seminal work in this field was carried out in the 
epidemiology section of the Pompidou Group where at the outset differences in the 
definition of first treatment demand were identified. In Dublin and certain other cities the 
term refers to first treatment contact, and only those clients who enter treatment for the first 
time ever are included. In other cities and in some London treatment centres the term has a 
wider meaning and refers to clients requesting treatment for the first time ever, regardless 
of whether they are taken on for treatment or not. The Dublin data are a measure of treated 
incidence, while the London data are a measure of the incidence of first treatment requests. 
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 First treatment demand serves two functions which will be elaborated on later in the 
methodology section. The first as a direct indicator of the demand on services, the second 
function as an indirect epidemiological indicator of trends in drug misuse in communities, 
or populations served by these services. 
 The collection of standard detail on the socio-demographic characteristics of clients, 
their past history of problem drug use, their former and present injecting and sharing 
practices provides information on clients seeking treatment which could be used to monitor 
change over time, and target specific groups for both treatment and preventive purposes. It 
would also permit more valid comparisons between clients attending Dublin and London 
treatment facilities. 
 A set of basic core data was agreed to between London and Dublin following a 
careful scrutiny of similar data collected elsewhere in Europe. In Dublin a single one page 
form was used to collect these data; in some London centres the same form was used, 
while in others these data were abstracted from centres’ existing data set. An 
accompanying set of instructions re completion of the form, definitions of key concepts, 
coding guide, drug classification, computer arrangements were all in place before the 
commencement of the pilot study. 
 The outcome and report (O’Hare and Hartnoll, 1989) demonstrated the feasibility of 
undertaking such a comparative study especially in the context of fairly similar legislation 
and drug policies in both cities. It provided interesting comparisons between clients and 
their drug practices in the two cities. It was also a most useful learning experience and in 
the light of one quite basic misunderstanding that arose between the two collaborating 
researchers, underlined the need for explicit written communication prior to the execution 
of such comparative studies. 
 The data set collected in the two cities has been implemented on a pilot basis in 11 
European cities, with some minor changes but with a more detailed protocol and set of 
instructions (Hartnoll, 1991). It is expected that such systems will be ongoing in most of 
the cities. 
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1.5 Government Role and Policy on Drug Misuse 
The Government plays a crucial role in all areas of problem drug use from supply to 
demand reduction and increasingly in international co-operation. 
Ireland has active links with a wide ranging number of international bodies including the 
European Community; the United Nations; World Health Organisation; Pompidou Group 
Council of Europe; CELAD; Ad Hoc Group on Drug Addiction; the TREVI Group on 
Police Co-operation; the Mutual Assistance Groups on Customs Co-operation, and 
Interpol. 
 The most recent statement on drug policy comes from the Government’s “Strategy 
to Prevent Drug Misuse”. Areas covered by this report concern an assessment of the drug 
problem in Ireland, supply reduction, demand reduction, manpower and training 
development, and international co-operation. 
 Some of the more interesting policy formulations include recommendations: to 
establish a national database which would use and integrate indicators developed by the 
Pompidou Group; to introduce whatever legislative action is necessary to strengthen the 
powers of the customs authorities to deal with persons importing prohibited drugs 
concealed in body cavities; to develop ‘Community Drug Teams’ under the direction of the 
regional health boards to operate with the involvement of general practitioners and other 
health professionals in targeted areas; to strengthen both formal and informal drug 
education programmes, including the related areas of drug misuse and AIDS and to 
maintain our commitment to European co-operation in the field of drug misuse. 
 The expansion of the existing database in Dublin to the country as a whole is being 
implemented on a regional basis, using the Health Boards as the units of administration. 
Structures are now in place in the Southern Health Board area to collect data on a range of 
indicators and to ensure accurate interpretation of information emanating from them. These 
data should enable the monitoring of drug misuse activity, identify trends and as such 
provide ongoing useful information for the prevention, treatment and rehabilitation of 
those affected. 
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CHAPTER 2 
Methodology 
2.1 Objectives of the Study 
The objectives of this study were two-fold 
− to implement the first treatment contact indicator 
− to establish a reporting system of information on the socio-demographic 
characteristics of treated drug users. 
 The first treatment contact indicator was piloted in the Dublin/London project and 
refers to the first ever entry to treatment by drug users who have never been previously 
treated for their drug problem. Data from this indicator serve two purposes. The first as an 
indirect indicator of trends in drug misuse, i.e., treated incidence, which may also reflect 
‘true’ incidence in the catchment population. For example, the rise in the number of opiate 
users attending for treatment at the National Drug Advisory and Treatment Centre in the 
late 1970s and early 1980s was taken as evidence of an epidemic of opiate addiction in 
Dublin. The subsequent stabilisation or decrease of new cases attending the Centre (the 
largest treatment centre in Dublin) was interpreted as evidence that the epidemic had 
peaked. While this example shows the potential epidemiological value of the first treatment 
contact indicator it must be stressed that this is a lagged indicator and that 21% of all opiate 
attenders at the above centre had, at the peak time of the epidemic, been using drugs for 
seven or more years prior to their first contact (Dean, O’Hare, O’Connor, et al, 1987). 
Furthermore other factors must be considered when interpreting data on first treatment 
contact, such as, the availability and acceptability of treatment services in the catchment 
area. 
 The second purpose of first treatment contact is as a direct indicator of the demand 
on services covered by the reporting system. Such information is of benefit to service 
providers and planners in enabling them to determine whether or not services are reaching 
the target populations e.g., women, generally seen as being slow to use such services, 
perhaps because they do not meet their needs, or methadone maintenance in the case of IV 
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drug users. The planned introduction of community drug teams will provide important data 
on the pick-up rate for this new service and by whom. 
 The establishment of an ongoing reporting system is the vehicle by which core 
socio-demographic information can be collected on first contacts, re-contacts and all 
contacts entering treatment in a given year with one or more of the specified centres in the 
Dublin catchment area. 
 As reporting systems are being established in other European cities with similar dual 
objectives and methodology, a future comparison of output will be feasible between cities. 
Some of the benefits accruing from this type of co-ordinated approach include improved 
interpretation of data, an early warning of changes in patterns and type of drug misuse, in 
routes of drug administration, and feedback on successful intervention policies. 
 In an Irish context these treatment data are the first of their kind to be gathered in a 
systematic way, and as already mentioned this approach is to be extended to the country as 
a whole. In addition to the benefits outlined above, findings from this study will suggest 
new areas of further investigation thereby providing an informed response to the treatment 
of drug misuse in this country. 
2.2 Catchment Area 
The study catchment area is that of the greater Dublin area at 504 km2, within Dublin 
county. According to the 1986 Census of Population the greater Dublin area comprised 
Dublin County Borough, its north suburbs (Fingal-part) and its south suburbs (Belgard-
part) together with Dun Laoghaire County Borough and its suburbs, with a population of 
920,956. (See Appendix B for a breakdown by age and sex of this figure). 
 The population increased by only 6% between 1981 and 1986. The principal 
difference seen in the age structure of the population between the two censuses was a 
decrease in the age groups of under 20 years and an increase in all other older age groups. 
2.3 Population Surveyed 
Persons who received treatment in 1990 from centres in the reporting system in the greater 
Dublin area and who reside there are the subject of our analysis. Twenty centres 
participated in the system (see Appendix C for a list of these centres and their service 
provision). Between them they cover the range of facilities available to drug users in the 
Dublin area such as, medical treatment including methadone, and non- medical care from 
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both statutory and voluntary services. As will be seen later in this chapter we believe that 
the group of drug users analysed is representative of those who seek treatment for their 
problem. Excluded are persons who receive treatment outside the greater Dublin area for 
example in the United Kingdom. However the common belief is that the group of people 
who ‘drift’ between the two countries probably enter treatment at some stage in Dublin and 
are included in our statistics. However this possible source of missing information on 
Dublin drug misusers should be the subject of a special research enquiry. 
2.4 Study Definitions 
The following are definitions of the principal terms or concepts used in this study. 
Drug Misuse 
The taking of a legal and/or illegal drug or drugs (excluding alcohol, other than as a 
secondary drug of misuse, and tobacco) which harm the physical, mental or social well-
being of the individual, the group or society. 
Drug Treatment 
Drug treatment is therapy given to clients in various specified centres. It may include 
medical treatment such as, de- toxification, methadone or drug-free programmes, and 
psychotherapy or non-medical modalities like counselling, individual or group therapy. 
Whereas therapy is generally provided by professional personnel it also includes persons 
employed by some centres who are deemed by them to have the necessary therapeutic 
skills, but lack formal qualifications. 
 Drug treatment may be provided in e.g., hospitals, therapeutic communities, 
residential centres, out-patient clinics, street agencies and prisons. Treatment does not 
include, however, information given over the telephone, or information solely related to 
social assistance or insurance entitlements. 
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Primary Drug 
The primary drug is the drug which the client alleges at the time of the current treatment 
contact is causing most problems and for which treatment is sought. 
Census or Point Treated Prevalence 
Census data refer to persons in treatment during a particular day or time period, rather 
similar to information from a census of the general population. For those in residential care 
the census day was 31 December 1989. However, for the majority of clients not in 
residential treatment a census count included clients who were in treatment for their drug 
problem in the 30 days prior to the census day. The census information comprises a 
baseline or starting point to which subsequent treatment contacts are added. 
One Year Treated Prevalence 
These data refer to all persons who received treatment for their drug misuse during the 
calendar year of 1990, including census data which comprise the beginning of this set of 
information and without which persons in treatment, as distinct from those coming into 
treatment, would have been omitted from the 1990 statistics. 
First Treatment Contact, or One Year Treated Incidence 
This output refers to clients who entered treatment for the first time ever in 1990 and had 
not previously been treated anywhere for their problem drug use. 
Details of the operational aspects of the above three sets of statistics are covered in the 
following chapter. 
2.5 Study Questionnaire 
A one page questionnaire or form designed for the EC Dublin/London pilot project was 
used to collect information from the participating centres in the catchment area of greater 
Dublin. Prior to the commencement of this study considerable public relations work was 
undertaken to identify and then ensure participation of centres providing treatment to drug 
users. The objectives and the benefits of the project were discussed and assurances 
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regarding the confidentiality of the data given i.e., that information from an individual 
participating centre would not be divulged without prior consent. 
 Each participating centre received information on the definitions of key concepts 
central to the data collection and instructions regarding how the form was to be completed. 
Particular attention was given to informing the treatment centres that the form was to be 
completed once during 1990 for each client who received treatment regardless of the 
number of contacts made by that client. A liaison person in the treatment centres was 
identified as having responsibility for the return of completed data on a regular basis to the 
Health Research Board. 
Copies of the study form, instructions used to complete the form, and the drug 
classification are contained in Appendix D. 
2.6 Coverage 
Each of the twenty centres identified as possible providers of treatment to drug users in the 
Dublin area was contacted and their participation in this project requested. All agreed to 
co-operate. A few said that whereas they had in the past provided such treatment they were 
not currently so doing. No information was received during 1990 for four of these named 
centres on the list. However provided that the possibility existed of clients presenting for 
treatment it appeared prudent to retain their agreed participation. Since 1990 some centres 
who then had no drug clients have since been approached for treatment. There is an 
understandable variation in the number of clients treated among the 16 centres who 
provided statistics on treated drug use. From our knowledge of service providers in the 
catchment area we feel confident that centres co-operating in the scheme represent almost 
complete coverage of treated drug misuse. The main gaps in our network are those general 
practitioners who e.g., provide methadone to opiate users; Mountj oy Prison, in particular 
the Separation Unit, which initially returned data to us but had to discontinue due to 
pressure of work. Discussions are in progress to include information for drug users who 
receive treatment while in Mountjoy Prison, thereby providing complete cover of all 
treated users in Dublin prisons. We are also conscious that middle class users evade the 
net. This may be due to the fact that their drug use has not reached a problem level, or that 
they receive treatment from persons or centres not yet participating in our reporting 
system. 
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2.7 Data Processing 
Completed forms are returned to the Health Research Board in sealed plastic bags for 
security reasons. Data are initially checked for completeness and accuracy and this process 
in some instances requires further clarification with the participating treatment centres. 
Anonymous information is entered on an IBM compatible PC and the software used is the 
Statistical Package for the Social Sciences (SPSS). 
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CHAPTER 3 
Findings 
The findings are presented under the two broad headings of 
− One year treated prevalence 
− Census and first treatment contact. 
In the following sections, numbers refer to cases and not to individuals. While there is no 
duplication of information within participating centres in the reporting system there is an element 
of double count between some centres. Examples of this are: where a client is attending one 
centre and receiving methadone maintenance from another; or where the probation service 
continues to counsel a client referred to another agency, thereby giving rise to an individual being 
counted twice or seen as two separate cases. 
This situation will be elaborated on in greater detail in the concluding section of this chapter 
dealing with Estimation of Rates for Treated Drug Misuse. 
3.1 One Year Treated Prevalence 
The operational definition of prevalence in this section refers to the number of cases in the 
greater Dublin area who received treatment for their drug misuse during 1990, without any 
distinction between old and new cases (N=2,037). This number includes clients in 
treatment who met with the census criteria at the beginning of 1990, together with those 
clients from each participating centre who entered treatment either as old or new cases 
during 1990, excluding those who were already in the census count. 
 These cases will be examined in greater detail under the following headings: 
(i) Socio-demographic characteristics; 
(ii) History of drug misuse; 
(iii) Injecting and sharing practices. 
Firstly, basic information for the above three sets of data will be presented as figures 
giving the percentage value for each variable, e.g., percentage of cases that are: male and 
female for sex; opiates, cannabis, and ‘other drugs’ for primary drug of misuse. Secondly, 
cross tabulations follow which provide a more composite picture of drug misusers and their 
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patterns of use, e.g., does a drug misuser’s sex have any bearing on whether or not he/she 
is living with another drug user? The percentage responses from these cross tabulations are 
compared with the expected values estimated in the basic analysis (see pp. 18, 24 & 28). 
Differences which occur are focussed on in the comments following each cross tabulated 
table. 
Socio-demographic Characteristics (valid %) 
The characteristics of prevalence cases are presented below in barchart format and refer to 
the valid percentage thereby excluding not known and not applicable data. Frequency data 
presented in Appendix A show the number of not known cases is small except for a few 
variables. 
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 Almost three quarters of the prevalence population were male, compared 
with a quarter who were female. 
 There was little difference in the distribution of cases between the two 
broad groupings of less than 25 years and 25 years and over. The mean age was 25 
years. 
 An analysis of living status showed that a little more than half the 
population, 51 %, had been living with their family of origin prior to their 
treatment contact; 27% with a partner, either a spouse or a cohabitee, of whom 
half or 13% lived with a drug misusing partner. The remaining 22% included 
those who were living alone, with friends, in an institution, homeless or as lone 
parents. 
 The vast majority, 82%, of prevalence cases were unemployed. The mean 
age left school was 14.7 with 44% having left before the official school leaving 
age of 15, and 3 8% at age 13 or 14. 
 For obvious reasons we are opposed to identifying communities within the 
catchment area associated with problem drug use. However, to ensure that 
appropriate resources to ameliorate the problem are made available we have cited 
area of residence information to the wider electoral areas. 
 Our catchment area covered 30 Census Electoral Areas. We were able to 
identify 55% of cases resident in four of these areas associated with inner city 
decay, or elsewhere with pockets of poor quality housing and high levels of 
unemployment and deprivation. 
 To provide more detail on the prevalence population the following cross 
tabulations are presented and commented on. 
 
 
 
 
 
 
 
 
 
19 
Table 1: One Year Treated Prevalence, Dublin 1990. 
Specified Socio-demographic Characteristics by Sex. 
Numbers and Percentages. 
Age  Male Female 
under 25 years N 
% 
731 
49.8 
249 
47.5 
25 years & over N 
% 
738 
50.2 
275 
52.5 
Living Status 
with family N 
% 
823 
56.9 
183 
35.2 
with partner, 
drug misuser 
N 
% 
121 
8.4 
132 
25.4 
with partner, 
not drug misuser 
N 
% 
218 
15.1 
48 
9.2 
other  285 
19.7 
157 
30.2 
Employment 
regular work N 
% 
162 
10.9 
37 
7.1 
unemployment N 
% 
1256 
84.8 
384 
73.3 
other  63 
4.3 
103 
19.7 
Age Left School 
under 15 years N 
% 
471 
40.1 
225 
54.0 
15 years & over N 
% 
704 
59.9 
192 
46.0 
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 Table 1 presents information on specified socio-demographic characteristics 
of treated cases by sex to determine possible differences between the sexes 
regarding their age, living status, employment and age left school. The comment 
which follows while relating to the table, also incorporates data shown in bar 
chart format on p. 18 which provides the expected proportion of all cases for 
each of the variables analysed. 
 There was no real difference between the sexes regarding age with males 
and females distributed more or less as expected between the two broad age 
groups of under 25 years and 25 years and over. 
 However, interesting differences emerged for drug misusers’ living 
arrangements prior to contact for treatment. When a comparison was made 
between men and women living with a drug misuser it can be seen that women 
(25%) were much more likely to be living with a drug misuser when compared 
with the expected percentage (13) and men much less so at 8%. The reverse 
pattern, though not so marked, showed that men were more commonly living 
with a non drug misuser than women. The higher than anticipated proportion of 
women returned as ‘other’ comprised mainly those living alone and lone parents. 
 Women were less likely to be unemployed than men when compared with 
the expected figures. It is relevant to note than the 20% of women in the ‘other’ 
designation referred principally to housewives. 
 Proportionally more women and less men than expected left school before 
the official school leaving age of 15. 
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Table 2: One Year Treated Prevalence, Dublin 1990. 
Specified Socio-demographic Characteristics by Age. 
Numbers and Percentages. 
Sex  Under 25 years 25 years & over 
Male N 
% 
731 
74.6 
738 
72.9 
Female N 
% 
249 
25.4 
275 
27.1 
Living Status 
with family N 
% 
619 
64.5 
370 
38.1 
with partner, 
drug misuser 
N 
% 
73 
7.6 
171 
17.6 
with partner, 
not drug misuser 
N 
% 
69 
7.2 
195 
20.1 
other N 
% 
198 
20.6 
234 
24.1 
Employment 
regular work N 
% 
83 
8.6 
111 
11.1 
unemployment N 
% 
786 
81.1 
824 
82.7 
other N 
% 
100 
10.3 
61 
6.1 
Age Left School 
under 15 years N 
% 
330 
41.5 
360 
45.9 
15 years & over N 
% 
466 
58.5 
424 
54.1 
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 Table 2 examines the same socio-demographic characteristics as the 
previous table by age group, and the following comment takes into account the 
expected values shown on p. 18 for the variables in question. The proportions of 
males to females were as expected in both the under 25 and 25 years and over 
age groups in a ratio of 3 : 1. 
 Clients in the younger age group were much more likely to be living with 
their family of origin, not surprisingly, than those in the older age category. 
Younger drug users were much less likely to be living with a partner whether a 
drug misuser or not, while the older users were more commonly living with a 
partner, particularly non drug misusers. The ‘other’ category is comprised of 
those living alone, with friends, as lone parents, homeless or in an institution. 
 Little difference emerged between the age groups unemployed with similar 
high proportions, of over 80%, in both age categories. 
 Younger drug users were somewhat more likely to have remained longer at 
school whereas those in the older age groups were less likely to have done so. 
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History of Drug Misuse (valid %) 
The history of drug misuse for the one year prevalence cases, using piecharts is shown below. 
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 The profile of drug misusers, using valid percentage data, shows that 80% reported that 
their primary drug of misuse, that is, the one which at the time of treatment contact was 
causing most problems and for which treatment was sought, was an opiate or opioid, chiefly 
heroin. An opiate is a natural derivative of the opium poppy, such as, heroin, morphine or 
codeine. An opioid is a synthetic drug, for example, methadone, pethidine or buprenorphine, 
with effects similar to that of an opiate. Sometimes the term ‘opiate(s)’ is used in this paper to 
include opioids. Twelve per cent had come for treatment for cannabis-related problems, and 
less than one per cent for cocaine misuse. Sixty eight per cent had injected their primary drug, 
by inserting a needle into a vein, muscle tissue or under the skin. This method is generally 
associated with opiate misuse. A similar proportion, 14%, either smoked or ate/drank their 
preferred drug. In this study both herbal and resin cannabis have been smoked, also heroin. 
Drugs mentioned as being eaten or drunk include morphine sulphate tablets (MST), 
dihydrocodeine (DHC), and minor tranquillisers. A small proportion sniffed their drugs such 
as solvents, glue, butane and also heroin. 
 When asked the age at which they had first used their named primary drug 66% 
admitted to having done so before the age of 20 the mean age being 19 years. Information 
relating to frequency of drug use in the month prior to treatment contact showed that during 
that time 66% used drugs on a daily or more frequent basis – over 90% of whom were opiate 
users – 15% less than daily and 19% were drug free. 
 The drug free category referred mainly to clients who: 
− had been recorded as drug free although on a methadone maintenance programme in 
the month previous; 
− were referred directly from prison where they had been drug free, or by a probation 
officer and who had stopped drug use during the remand period, or by Narcotics 
Anonymous; 
− sought counselling for their drug problem, as many only seek counselling and support 
when they are drug free in an attempt to “look behind the drugs and get grounded”, 
thereby gaining an understanding of their problem and avoiding a future relapse. 
Almost half the population, 49%, had been actively misusing their preferred drug for less than 
5 years, 34% from between 5-9 years with 17% having done so for 10 or more years. 
 When queried about misuse of a secondary drug the majority, 51 % of drug misusers 
again stated an opiate. Because 80% had also reported an opiate as their primary drug of 
misuse there was an overlap between those for whom such a drug was both their primary and 
secondary choice. Examples of this are heroin in combination with MST, DHC, methadone or 
palfium. To some extent drug choice is dependent on availability. Cannabis was the next 
preferred drug. Whereas the definition of drug misuse precluded alcohol as a stated drug of 
primary misuse it could be recorded as a secondary one. Eleven per cent admitted to its use in 
combination with a primary drug. For 18% of users no secondary drug was recorded. 
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Table 3: One Year Treated Prevalence, Dublin 1990. 
Specified Characteristics by Primary Drug. Sex 
Numbers and Percentages 
Sex  Opiates Other Drugs 
Male N 
% 
 1191 
 73.8 
 
 298 
 73.4 
Female N 
% 
 422 
 26.2 
 108 
 26.6 
Age 
under 25 years N 
% 
 713 
 45.0 
 263 
 65.6 
25 years & over N 
% 
 870 
 55.0 
 138 
 34.4 
Age First 
Used Drugs 
under 20 years N 
% 
 943 
 62.2 
 319 
 83.5 
20 years & over N 
% 
 574 
 37.8 
 63 
 16.5 
Duration of 
Drug Use 
under 5 years N 
% 
 679 
 47.2 
 207 
 55.6 
5-9 years N 
% 
 509 
 35.3 
 101 
 27.2 
10 years & over N 
% 
 252 
 17.5 
 64 
 17.2 
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 Table 3 elaborates on selected characteristics of clients who cited an opiate 
(including an opioid) as their primary drug of misuse compared with those whose 
primary drug was other than an opiate. It should be recalled that in 8 out of 10 
cases in this study an opiate was named as the primary drug on treatment contact 
and as a consequence the numbers involved in the ‘other drugs’ category are 
small. Differences which emerge between these two broad drug groups must 
therefore be regarded cautiously. 
 From the table we see that the breakdown between the sexes within the 
opiate and ‘other drugs’ categories was similar to the profiles (pp. 18 & 24). 
 Age had an effect on the choice of drug users’ primary drug as 
proportionally more cases in the ‘other drugs’ group were aged under 25, while 
conversely higher percentages of opiate cases were in the older age category. 
 Clients who first used drugs from the younger age group were more likely 
to have used a drug other than an opiate. 
 The ‘other drugs’ category contained a higher proportion of cases in the 
under 5 years duration of drug use period than the opiates one. 
 Interestingly there was no difference between the two drug using groups 
and the expected figure for the duration period of 10 years or over at 17%. 
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Injecting and Sharing Practices (valid %) 
The salient features to emerge for treated cases who injected or shared their drugs during 
1990 are shown below. 
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 The majority, or 80%, acknowledged having at some time 
injected their drugs. 
 On treatment contact 65% of those who had ever injected 
stated that they were currently injecting. 
 More than eight in ten of those who ever injected drugs had 
at some time in the past shared their injecting equipment, the 
proportion who were currently sharing dropped to 17% (245) 
when questioned on treatment contact. 
 Most of these (92%) were aged under 25 when they first 
started the practice of drug injecting; the mean age for first 
injecting was 19 years. 
 The following Tables 4 and 5 provide further information on 
specified characteristics of those who had ever injected with 
those currently injecting and currently sharing. 
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Table 4: One Year Treated Prevalence, Dublin 1990. 
Specified Characteristics of these who had Ever 
Injected by Currently Injecting. 
Numbers and Percentages. 
 Currently Injecting 
Sex  Yes No 
male N 
% 
752 
75.9 
384 
72.2 
female N 
% 
239 
24.1 
148 
27.8 
Age 
under 25 years N 
% 
448 
46.1 
229 
43.7 
25 years & over N 
% 
523 
53.9 
295 
56.3 
Primary Drug 
of Misuse 
opiates N 
% 
973 
98.4 
480 
90.7 
other drugs N 
% 
16 
1.6 
49 
9.3 
Ever Injected 
yes N 
% 
991 
100.0 
532 
100.0 
no N 
% 
- 
- 
- 
- 
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 As can be seen from Table 4 of those who had ever injected 
991 cases, or 65% (as shown in the figure relating to injecting 
and sharing practices p. 28) were currently injecting their drugs. 
Slightly higher proportions of men and lower of women than 
expected were currently injecting their drugs. Somewhat lower 
percentages of the younger age group were currently injecting 
and higher percentages among the older clients. Drugs used by 
those who had ever injected were predominantly opiates, with 
less than 2% injecting other drugs, such as minor tranquillisers 
and cocaine. 
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Table 5: One Year Treated prevalence, Dublin 1990. 
Specified Characteristics of those who had Ever 
Injected by Currently Sharing. 
Numbers and Percentages. 
 Currently Sharing 
Sex  Yes No 
male N 
% 
156 
63.7 
912 
74.7 
female N 
% 
89 
36.3 
267 
22.6 
Age 
under 25 years N 
% 
101 
42.6 
537 
46.1 
25 years & over N 
% 
136 
57.4 
629 
53.9 
Primary Drug 
of Misuse 
opiates N 
% 
245 
100.0 
1114 
94.6 
other drugs N 
% 
- 
- 
63 
5.4 
Currently 
Injecting 
yes N 
% 
245 
100.0 
653 
56.0 
no N 
% 
- 
- 
514 
44.0 
 
 
 
 
32 
 Table 5 presents information for those who had ever injected 
and were currently sharing their injecting equipment. Of those 
who had ever injected 245 or 17% (see p. 28) were currently 
sharing their drugs. However here we see that women were 
proportionally more likely than expected to be sharing their 
injecting equipment. A higher than anticipated percentage of drug 
users in the older age group were currently sharing compared 
with those in the younger age category. Opiates were the only 
drugs involved in the sharing practice. 
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3.2 Census and First Treatment Contact 
Census cases are those, already defined in greater detail, who were in treatment on January 
1 1990, N cases = 462. Such cases would include a mix of those with both short and long 
term lengths of stay in treatment. The majority, we believe, refer to the somewhat older 
methadone maintenance cases from the large Drug Treatment Centre Board. 
First Treatment Contact is the current estimate of treated incidence relating to those clients 
who received treatment for the first-ever time during 1990, N cases = 624. 
 A comparison of these two distinct treatment classes was considered to be a useful 
exercise. It provides a way of documenting possible differences between the two client 
groups regarding, for example, age, primary drug of misuse, and current injecting 
practices. Such findings are of value in themselves but in addition afford insights for 
treatment and policy approaches. 
 The comparative analysis of Census and First Treatment Contact data which follows 
takes the approach used for the prevalence data (see p. 17). This consists of providing basic 
information, followed by cross tabulations. Where proportional differences between the 
variables analysed in these tables occur, they are compared with the expected values 
established initially and commented on. 
 A higher proportion of males, 75%, were in the first contact group than the 
census one at 66%. Conversely there was almost 10% more females in the census 
group than the first contact one. 
 As is in order more young people, 69%, were making their first contact 
with a treatment centre than those who were in treatment, 43%. Following on 
from the fact that the first treatment group was the younger of the two, more in 
that group, 61%, were living with their family of origin than in the census 
category of 40%. 
 Drug users from the older census cases were more likely to be living with a 
drug misusing partner, in fact were twice as probable to be living with a partner 
than the first contact group. 
 Differences between the two groups were not as marked for employment, 
with the first contact category containing a slightly higher proportion in regular 
employment, and more unemployed in the census category. 
 More first contact drug misusers had remained on at school after the school 
leaving age of 15 than census cases. 
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Socio-demographic Characteristics (valid %) 
A profile of the socio-demographic characteristics of census and 
first treatment contact case is presented here. 
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Table 6: Census and First Treatment Contact, Dublin 1990. 
Specified Socio-demographic Characteristics by Sex. 
Numbers and Percentages. 
  CENSUS FIRST CONTACT 
  Male Female Male Female 
Age 
Under 25 years N 
% 
130 
43.2 
67 
43.8 
3.22 
70.0 
103 
66.0 
25 years & over N 
% 
171 
56.8 
86 
56.2 
178 
30.0 
53 
34.0 
Living Status 
with family N 
% 
133 
44.6 
48 
30.8 
307 
67.2 
68 
43.6 
with partner, 
drug misuser 
N 
% 
28 
9.4 
38 
24.4 
20 
4.4 
26 
16.7 
with partner 
not drug misuser 
N 
% 
53 
17.8 
17 
10.9 
48 
10.5 
12 
7.7 
other N 
% 
84 
28.2 
53 
34.0 
82 
17.9 
50 
32.1 
Employment      
regular work N 
% 
30 
10.0 
3 
1.9 
49 
10.6 
19 
12.2 
unemployed N 
% 
257 
86.0 
124 
80.5 
370 
80.3 
104 
66.7 
other N 
% 
12 
4.0 
27 
17.5 
42 
9.1 
33 
21.2 
Age Left School      
under 15 years N 
% 
119 
44.6 
78 
58.6 
120 
35.3 
47 
42.7 
15 years & over N 
% 
148 
55.4 
55 
41.4 
220 
64.7 
63 
57.3 
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 Table 6 provides additional detail for specified socio-demographic 
characteristics by sex for census and first treatment contacts, see also data 
presented on p. 35. There were few differences in the male female groups in 
terms of age for either the census or first contact cases, except for a small 
shortfall for younger first contact females. 
 Higher proportions of men and less women than expected from both 
treatment modalities were living with their family of origin, markedly so for the 
first contact clients. Conversely percentages of women living with a drug 
misusing partner were higher than anticipated. Almost a quarter of census 
women were in such a relationship compared to 17% of first contacts. Census 
and first contact male drug users were somewhat more likely than their female 
counterparts to be living with a non drug user. 
 The proportions of unemployed men were somewhat higher than those for 
women. 
 Proportionally more women and less men than expected, for both census 
and first treatment clients, left school aged under 15 years. 
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Table 7: Census and First Treatment Contact, Dublin 1990. 
Specified Socio-demographic Characteristics by Age. 
Numbers and Percentages. 
CENSUS FIRST CONTACT  
Under 25 
years 
25 years & 
over 
Under 25 
years 
25 years & 
over 
Sex 
male N 
% 
130 
66.0 
171 
66.5 
322 
75.8 
138 
72.3 
female N 
% 
67 
34.0 
86 
33.5 
103 
24.2 
53 
27.7 
Living Status      
with family N 
% 
97 
49.5 
82 
32.8 
310 
73.6 
60 
32.3 
with partner, 
drug misuser 
N 
% 
18 
9.2 
46 
18.4 
22 
5.2 
24 
12.9 
with partner 
not drug misuser 
N 
% 
20 
10.2 
50 
20.0 
16 
3.8 
44 
23.7 
other N 
% 
61 
31.1 
72 
28.8 
73 
17.3 
58 
31.2 
Employment      
regular work N 
% 
14 
7.2 
19 
7.6 
37 
8.8 
30 
16.0 
unemployed N 
% 
162 
83.5 
214 
85.3 
320 
75.8 
147 
78.6 
other N 
% 
18 
9.3 
18 
7.2 
65 
15.4 
10 
5.3 
Age Left School      
under 15 years N 
% 
80 
46.8 
115 
51.6 
115 
37.0 
50 
36.5 
15 years & over N 
% 
91 
53.2 
108 
84.4 
196 
63.0 
87 
63.5 
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 Table 7 looks at the possible relationship between age and a range of 
selected socio-demographic characteristics for the treatment contacts, see also 
data presented on p. 35. The proportions were as expected in the analysis of age 
group by sex for census cases. Where first treatment contact is concerned women 
from the older age category were more likely to present later for treatment than 
men. 
 The younger age groups for both census and first treatment contact were 
more commonly living with their families; the difference was more marked than 
might be anticipated for the first contact cases. Proportions were higher in the 
older age group of 25 years and over for those living with a drug misuser in both 
treatment modalities, but surprisingly higher than expected in the first treatment 
one. A similar trend existed for drug users living with a non using partner. 
 The age distribution of census and first contact cases regarding their 
unemployment status was similar. However a higher than anticipated percentage 
of the 25 years and over first contact cases were in regular work. 
 As earlier remarked first contact clients remained on longer at school than 
census ones. This table shows no difference between the younger and older first 
contacts for that finding. 
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History of Drug Misuse (valid %) 
A summary history of drug misuse among census and first 
Treatment contact cases can be seen below. 
 
40 
This profile shows that opiates were the preferred primary drug for both census 
and first contacts. It is not surprising that a higher percentage, 86%, in the census 
group named an opiate, than the first contact group at 61 %. Of interest is that a 
quarter of clients on their first treatment contact reported cannabis as their 
primary drug, in contrast to only 6% in the census category. 
 Differences between the two treatment groups emerged for route of 
administration of their primary drug, with the majority of census cases, 73%, 
injecting compared with less than half, or 48%, in the first contact class. A high 
proportion of the latter group 28%, smoked their drug. This can be allied to the 
relatively high number who stated cannabis as their primary drug. Approximately 
two thirds of census cases had first used their stated primary drug before the age 
of 20, a slightly higher percentage, 72% of first contacts having so done. More 
detailed analysis shows that first contact women were more likely than men to 
have first used their primary drug at an older age. 
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History of Drug Misuse (contd.) 
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 Daily or more frequent use of drugs was engaged in by more than half the 
two groups in the month before treatment contact. Reasons from participating 
centres have already been noted for the recording of drug free clients (see p. 25). 
However the higher proportion of those in the census group at 34% compared 
with 15% for first treatment contact must be queried. All centres had been sent a 
memo reminding them that census data should refer to the time prior to contact 
with their centre. It was possible to establish that those on a methadone 
programme in the Drug Treatment Centre Board, the only service in this 
reporting system then providing such a programme, returned only 2.7% of clients 
in their annual prevalence count, including census, as drug free. Therefore, the 
recording of drug free by the treatment centres referred principally to reasons 
recorded earlier. Notwithstanding, a question referring to “drug frequency in the 
past month” on a census form is open to misinterpretation and should be 
reconsidered for future use. 
 Because of the on average older age of the census category 24% from that 
group had been actively using drugs for 10 or more years in contrast to 9% of the 
first treatment clients. 
 Treatment in Dublin is centred predominantly on problems with opiates as 
seen from the high proportion who cite such a drug as their primary one. The 
same pattern emerged for secondary drug with opiates first on the list for census 
and first contact clients. Alcohol plays a small but significant role in both 
treatment groups, as in 15% of cases in each group it was used in association 
with a primary drug. 
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Table 8: Census and First Treatment Contact, Dublin 1990. 
Specified Characteristics by Primary Drug. 
Numbers and Percentages. 
CENSUS FIRST CONTACT  
Opiates Other 
Drugs 
Opiates Other 
Drugs 
Sex 
male N 
% 
257 
65.1 
45 
69.2 
284 
75.5 
180 
74.1 
female N 
% 
138 
34.9 
20 
30.8 
92 
24.5 
63 
25.9 
Age 
under 25 years N 
% 
150 
38.6 
47 
73.4 
243 
65.1 
179 
74.6 
25 years & over N 
% 
239 
61.4 
17 
26.6 
130 
34.9 
61 
25.4 
Age First Used Drugs 
under 20 years N 
% 
241 
63.3 
57 
90.5 
233 
65.3 
190 
83.7 
20 years & over N 
% 
140 
36.7 
6 
9.5 
124 
34.7 
37 
16.3 
Duration of Drug Use 
under 5 years N 
% 
133 
35.9 
29 
47.5 
234 
67.4 
151 
66.8 
5 – 9 years & over N 
% 
145 
39.2 
19 
31.1 
82 
23.6 
55 
24.3 
10 years & over N 
% 
92 
24.9 
13 
21.3 
31 
8.9 
20 
8.8 
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 In Table 8 the primary drug of misuse categories, except for opiates which 
include opioids, have been combined under ‘other drugs’, because the number 
involved is small. Information shown on pp. 35, 40 & 42 are used in the 
following analysis. As the opiate group comprises 80% of all drug cases, the 
‘other drugs’ category must be viewed with caution because of the small 
numbers and the heterogeneity of the ‘other’ categories. As expected the opiates 
and ‘other drugs’ categories for both census and first treatment contact contained 
higher male than female proportions. 
 There was little difference in percentages between opiates and ‘other drugs’ 
by age except for the younger age group of census misusers of ‘other drugs’. 
There the proportion was much higher than expected. 
 Proportionally higher numbers in the census and first contact groups had 
commenced using drugs, other than opiates, before the age of 20. 
 Between the opiates and ‘other drugs’ by duration of use differences from 
expected levels did not emerge except for census clients where almost half had 
been on drugs other than opiates, for less than 5 years compared to 36% of opiate 
users. 
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Injecting and Sharing Practices (valid %) 
The figures which follow highlight the main features of injecting And sharing practices 
among the census and first treatment contact cases. 
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 A much higher percentage of census cases at 86, had ever injected their 
drugs than those in the first contact category at 59. Subsequent information refers 
to that group of ever 
injected. 
 A higher proportion, 69%, of first contact clients were currently injecting 
compared to 54% of the census group. Conversely, a lower percentage of first 
contacts, 69, had ever shared their equipment, while the percentage for census 
cases was 22 points higher at 91. Similarly a lower proportion of first contact 
clients were currently sharing, 17, versus 26 for the census group. 
 We see that almost all those, 94% who injected their drugs had done so 
before the age of 25 years in the census group, the proportion was almost 
identical for the first contact group at 93%. 
 A relevant point to be elaborated on is the higher proportion of census drug 
takers than first treatment contacts who were drug free referred to on p.43. This 
means that about one third fewer census clients who had ever injected were 
currently using drugs or injecting and sharing, and has an effect on the 
comparative statistics between the two groups. This drop in drug taking by 
census clients may or may not reflect a firm decision by an older age group of 
users. 
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Table 9: Census and First Treatment Contact, Dublin 1990. 
Specified Characteristics of those who had Ever 
Injected by Currently Injecting. 
Numbers and Percentages. 
CENSUS FIRST CONTACT  
Currently Injecting Currently Injecting 
 Yes No Yes No 
Sex 
male N 
% 
124 
60.2 
124 
70.5 
180 
80.7 
76 
75.2 
female N 
% 
82 
39.8 
52 
29.5 
43 
19.3 
25 
24.8 
Age 
under 25 years N 
% 
76 
37.1 
75 
43.4 
157 
71.4 
58 
57.4 
25 years & over N 
% 
129 
62.9 
98 
56.6 
63 
28.6 
43 
42.6 
Primary Drug 
of Misuse 
opiates N 
% 
205 
99.5 
163 
92.6 
220 
98.7 
82 
81.2 
other N 
% 
1 
0.5 
13 
7.4 
3 
1.3 
19 
18.8 
Ever Injected 
yes N 
% 
206 
100.0 
176 
100.0 
223 
100.0 
101 
100.0 
no N 
% 
– 
– 
– 
– 
– 
– 
– 
– 
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 Table 9 provides additional information for census and first contact clients 
to that presented in the figure relating to injecting and sharing practices (p. 46). 
There it was observed that 86% of census cases and 59% of first contacts had 
ever injected their drugs in the past. This table shows that 206 or 54% of census 
cases who had ever injected were currently injecting; the figure for first contact 
cases was 223 or 69%. 
 A higher proportion of women than expected were currently injecting in the 
census group and a lower percentage in the first treatment one. Clients who were 
currently injecting were more likely to come from the 2 5 and over census age 
group. The drugs that clients injected in both treatment groups were primarily 
opiates. 
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Table 10: Census and First Treatment Contact, Dublin 1990. 
Specified Characteristics of those who had Ever 
Injected by Currently Sharing. 
Numbers and Percentages. 
CENSUS FIRST CONTACT 
Currently Sharing Currently Sharing 
 
Yes No Yes No 
Sex 
male N 
% 
48 
51.6 
187 
69.3 
34 
65.4 
208 
82.5 
female N 
% 
45 
48.4 
83 
30.7 
18 
34.6 
44 
17.5 
Age 
under 25 years N 
% 
31 
33.7 
112 
41.9 
35 
67.3 
168 
66.9 
25 years & over N 
% 
61 
66.3 
155 
58.1 
17 
32.7 
83 
33.1 
Primary Drug 
of Misuse 
opiates N 
% 
93 
100.0 
256 
94.8 
52 
100.0 
231 
91.7 
other drugs N 
% 
– 
– 
14 
5.2 
– 
– 
21 
8.3 
Currently Injected 
yes N 
% 
93 
100.0 
100 
37.0 
52 
100.0 
153 
61.7 
no N 
% 
– 
– 
170 
63.0 
– 
– 
95 
38.3 
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 Table 10 is concerned with the current sharing of drugs by clients who 
entered treatment either as census or first treatment cases. From information on 
an earlier figure (p. 46) we see that 26% of census cases who had ever injected 
were currently sharing compared with 17% of first contact clients. 
 Census and first contact women were much more likely than expected to be 
sharing their injecting equipment in both of these treatment categories. Drug 
users in the older age group of 25 years and over who were sharing were 
proportionally over represented in the census group, while the difference was 
less marked for first contact cases. Opiates were the only drugs implicated in 
current drug sharing among both treatment categories. 
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33 Estimation of Rates for Treated Drug Misuse 
Definitions of the three basic concepts 
one year treated prevalence, 
census, or point treated prevalence, and 
first contact, or one year treated incidence 
have been noted earlier. What follows here is an explanation of how rates of treated drug 
misuse for these three periods have been estimated. Rates are compiled for a 15-39 age 
group as 95% of drug users in this study were in that age range. 
 In the Dublin Drug Treatment Reporting System all participating centres are 
provided with written instructions regarding definitions of key concepts, such as, drug 
treatment and first treatment contact. In addition, designated persons in each centre have 
been trained in how these instructions are to be followed when completing the data 
collection form. Information reported on here refers to the first year of operation of the 
system during which some teething problems occurred. Some were due to our lack of 
anticipation of problems that arose, and others to pressure of work within treatment centres 
or their lack of familiarity with the requirements of the reporting system. 
 The determination of rates for each of our three measures of treated drug misuse 
involves (i) the definition of cases, (ii) the population from which they are drawn, and (iii) 
the time period involved. Leaving the first requirement aside for the moment, the 
population from which drug cases come is that of the greater Dublin area. As a 
consequence only those resident in that area were eligible for inclusion in the system and 
information returned to us regarding clients from outside this catchment area were 
excluded from the study (see Appendix B for details of the population of the greater Dublin 
area). 
The time period involved differs for each of the measures. The term one year treated 
prevalence is used to stress that figures derived from treatment centres reflect contacts with 
specified, usually specialist services, and not the true frequency of drug misuse in the 
Dublin area. However, any research strategy must begin with the known and work toward 
the unknown. 
There are two main components in a one year treated prevalence rate. The first is the 
number of clients on census day together with those non-residential clients who received 
treatment for their drug problem in the 30 days prior to that date, giving a point treated 
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prevalence or census count. The second component is the number of clients who received 
treatment with the specified services during the year following the census day and who are 
not included in the census figure. This second component includes those clients who enter 
treatment for the first ever time and comprise a one year treated incidence figure. 
 Returning now to the importance of case definition. If rates are to be computed for 
the three time periods cases must relate to persons. It can confidently be said that there was 
little or no duplication of individuals reported to the Health Research Board from the 
treatment centres, as all forms are manually checked prior to entry to the computer and 
again in the computer at the end of the year to detect duplicate client numbering within 
centres. There was, however, an element of double count between centres. Our way of 
dealing with this problem was the inclusion of a question on the intake form relating to 
“currently in contact with other centres”? and “if yes, specify”. In this context ‘currently’ 
referred to within the past 30 days. When the form is revised we plan to relate the question 
to received or receiving treatment since January 1st last at any other Dublin treatment 
centre. This altered approach, together with the use of clients’ date of birth, would further 
reduce the duplication of cases within the system. However, given the anonymous nature 
of this procedure we may always have to accept some degree of double count, confirmed 
by evidence from other European cities where, in addition, initials of forename and 
surname are collected. 
 Other reasons for excluding data on the grounds of case definition included 
information for clients not resident in the catchment area and for those whose primary drug 
of misuse was alcohol. 
 In our instruction re completion of the form and in our discussions with treatment 
centre personnel it is always stressed that forms should not be completed unless an entry to 
treatment, as defined, has been made. Initial assessments where clients do not return to 
commence treatment are excluded. 
 What follows is a critical look at our data with the objective of differentiating 
between cases and persons thereby reaching an estimate of persons in receipt of treatment 
for each of the time periods involved. 
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One Year Treated Prevalence 
The recorded figure refers to 2037 cases of which 
 1400 were not in contact with another centre or 1400 persons 
 504 were in contact estimated at half or 252 persons 
 133 were unspecified re centre contact of which  
 67 were presumed not in current contact or 67 persons 
 66 were presumed in contact, estimated at half or 33 persons 
 ____________ 
   Total 17 52 persons 
Census or Point Treated Prevalence 
The recorded figure refers to 462 cases of which 
 327 were not in contact with another centre or 327 persons 
 118 were in contact estimated at half or 59 persons 
 17 were unspecified re centre contact of which 
 9 were presumed not in current contact or 9 persons 
 8 were presumed in contact, estimated at half or 4 persons 
 ___________ 
   Total 399 persons 
First Contact or One Year Treated Incidence 
The recorded figure refers to 624 cases of which 
 507 were not in contact with another centre or 507 persons 
 84 were in contact, estimated at half or 42 persons 
 33 were unspecified re centre contact of which 
 17 were presumed not in contact or 17 persons 
 16 were presumed in contact, estimated at half or 8 persons 
 ___________ 
   Total 574 persons 
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An anomaly can be seen in the First Contact or One Year Treated Incidence data where 84 
cases were recorded as in current contact with another centre. According to instructions 
clients who are making their first ever contact for treatment cannot be currently in contact 
with another centre (because of the temporal sequence where one contact must preceed the 
other). We believe this error arose largely from incorrect recording of the never previously 
treated question. 
 In conclusion our estimates for the number and rate of persons who received 
treatment for their drug problem from centres in the greater Dublin area in 1990 are 
In Treatment Treatment Contact Census* 
(Jan 1 1990) (during year 1990) (Dec 1989) 
399 1353 of whom 574 X 
 were never 
 previously treated 
One year treated prevalence N 399 + 1353= 1752 
  Rate 4.5 per 1000 of the pop. 
    aged 15-39 
Census or point treated N 399 
Prevalence  Rate 1.0 per 1000 of the pop. 
    aged 15-39 
First contact or one year  N 574 
treated incidence  Rate 1.5 per 1000 of the pop. 
    aged 15-39. 
* December 1989 census data = In treatment on January 1 1990 
We are not happy with the estimate of one year treated incidence given above and believe 
it to be an overestimation of the actual figure. Similar difficulties in identifying unique 
individuals in the incidence of problem drug use in the Wirral were noted (Parker, Bakx, 
and Newcombe, 1986: 120-132). Estimates arrived at by us are somewhat analogous to the 
approach adopted by them. 
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CHAPTER 4 
Discussion 
Age 
There is evidence to suggest that the group of treated drug misusers in the greater Dublin area 
1990, is older than groups who received treatment in earlier years. As 1990 represents the first 
year for which information is available from the Drug Treatment Reporting System it is not 
possible to make comparisons with similar data for former years. However, information is 
available from the National Drug Advisory and Treatment Centre (Dean, Kelly, O’Hare et al, 
1985) now the Drug Treatment Centre Board, which shows that the percentage of treated clients 
aged 25+ was 
37% in 1981 
35% in 1982 
40% in 1983 and 
51% in 1990 (present study). 
Despite some differences in coverage and definition both sets of data refer to clients from the 
same population base. Since 1983 there has been a decline in the proportion of first contacts with 
a corresponding increase in the number of re-contacts (personal communication. Drug Treatment 
Centre Board). That may indicate ongoing treatment of former cohorts. Some idea of this ageing 
process can be gleaned from the fact that first contact clients of this study are considerably 
younger than those identified during the census period. There was a full 26 percentage points 
difference between the two groups. Regrettably we have no current information on the length of 
time in treatment for the census group, but there is a longer duration time on drugs for that group 
than the first contact one suggesting perhaps a longer time in treatment. 
 While Home Office Addict Notification Statistics for the United Kingdom need to be 
interpreted cautiously, due to incomplete coverage and reference to opiate and cocaine addicts 
only, they are still a useful indicator of underlying drug misuse trends. As in Dublin, notifications 
of all treated drug addicts between 1987 and 1990 inclusive refer to an ageing group, 67% aged 
25 or more in 1990 compared to 60% in 1987 (United Kingdom Home Office, 1991:6b), in fact 
much older than their Dublin counterparts. A London study (Hartnoll, Power, Daviaud et al, 
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1989) of regular drug users attending six local treatment services showed the same high 
percentage of 69% aged 25 years or more. 
 A recent national survey in France of 4,846 drug abusers attending a representative sample 
of treatment centres (Facy, Rosch, Angel et al, 1991) showed a marked increase in age when 
compared to an earlier study. In 1986,.44% of attenders were aged 25 or more. 
 Preliminary information from the Pompidou Group study on the Development of 
Treatment Reporting Systems in Europe (Hartnoll, 1991) shows Dublin with the lowest mean age 
for census clients (December 1990) at 25.7 years, with 43% aged under 25. Of the other cities in 
the study the mean age for clients was almost six years older in Copenhagen and eight in 
Amsterdam. While census data are not in all cases representative for cities they do indicate a 
trend of older long term users in those cities like Amsterdam, Copenhagen and Stockholm with a 
longer history of problem drug use. 
 Available data for all treated drug users (as distinct from census clients only) show current 
Dublin users to be younger than most of their European counterparts, with the exception of 
Lisbon and Scotland. Recently released figures from the new Scottish drug misuse database 
(Scottish Health Services, 1992) showed a surprising 56% of clients were aged under 25. This 
compares with 49% of Dublin clients for approximately the same time period. 
Sex 
In common with change over time in the age structure of the treated drug population in the 
Dublin area, the male/female ratio likewise seems to have altered. Using the same data source as 
for age shows a decline in the male proportion over time, with a corresponding increase in the 
female one, as follows the male/female ratio was 
3.9:1 in 1981 
3.6:1 in 1982 
3.1:1 in 1983 and 
2.8:1 in 1990 (present study). 
The male/female ratio for all drug addicts reported to the Home Office (United Kingdom Home 
Office, 1991:6a) was approximately 2.6:1 for the four year period 1987 to 1990, very similar to 
the current Dublin one. The male/female ratio for the London study, mentioned above, was less 
than two males to every female. In the French national survey the male/female ratio was 3:1 in 
1986. A study of 1214 Italian heterosexual drug users during the period 1985-1987 showed a 
similar male female ratio (Sasse, Salmaso, Conti et al, 1991). Data from the Dublin Ana Liffey 
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Drug Project show the same trend (Annual Report, 1991). Information from these combined 
sources suggests that more women are coming forward for treatment but at what stage in their 
drug careers? 
 An important point to emerge in this study was differences in the male/female ratio 
between the census and first contact groups. The ratio for the census group was 1.9:1 while the 
first contact male/female ratio at 3.0:1 showed a marked male predominance and female shortfall. 
This gender difference will be commented on later. 
Living Status 
Fifty one percent of treated drug misusers in Dublin in 1990 were living with their family of 
origin. As expected a higher proportion of the younger first treatment group, 61%, were so doing 
and correspondingly a lower proportion (40%) of the census group. These proportions are high, 
when compared with 27% of all clients in a similar situation in London at the time of a joint pilot 
study with Dublin (O’Hare and Hartnoll, 1989), and with the French study findings of 45% – 
further outcome from the Development of Treatment Reporting Systems in Europe is pending. 
 The explanation must lie in how the family functions in Ireland, as distinct from most 
European cultures. In 1986, the most recent census year for which such data are available, 
children aged under 15 years made up 29% of the Irish population. Compared to other European 
countries this proportion is very high. In fact among OECD countries only Turkey has a higher 
proportion of children (Nolan and Farrell, 1990: 7-8). 
 Whereas recent changes in the patterns ofnuptiality and fertility, the main demographic 
variables which define the family, have brought us closer to the European norm (Clancy, 1991) 
the traditional nuclear family still predominates. Furthermore a high proportion of unmarried 
children continues to live with their family of origin. According to the 1986 Census of 
Population, 44% of households (97% of the Irish population) contained 60% of persons, 
consisting of one or more unmarried children of any age (Nolan and Farrell, 1990: 11-12). 
 In addition to structural features of the Irish nuclear family economic necessity and high 
levels of unemployment deter young people from leaving home, particularly if emigration outlets 
are blocked. 
 The present study findings showed that a higher than expected percentage of females than 
males were living with a drug misusing partner, which could be either a husband or cohabitee. 
Confirmation of this gender preference of a partner comes from a recent Italian study which 
showed that females were more likely to have drug-using partners, while males were more likely 
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to have non drug-using partners. (Sasse, Salmaso, Conti et al, 1991). In the Dublin context this 
was particularly true of the first contact group. 
Gender 
Important gender differences emerged from this study showing that women were more likely than 
men to have first used their primary drug at an older age, and were older when they presented for 
treatment for the first time. These findings go some way towards explaining differences in the 
male female ratio, noted earlier, of almost 2:1 for census cases and 3:1 for first contact clients. 
They further substantiate the belief of many drug workers that women tend to present later for 
treatment, if at all (Woods, 1992 : 11). 
 Additional differences between the sexes which should be highlighted relate to higher 
proportions of women than men living with a drug misusing partner and currently sharing 
injecting equipment. These are areas which warrant further study. 
 While there is general recognition of the legitimacy of research and treatment of women as 
a ‘special population’ within the substance abuse field, there is little evidence that such work has 
been carried out. A special issue on women and drug abuse entitled Women 2000 (United 
Nations, 1987) suggests that this in part stems from the fact that more male than female subjects 
have been used for research. However, they note that epidemiological studies have shown 
consistent differences in drug use by men and women including higher levels of personal distress 
such as, depression and anxiety and lower levels of self-esteem experienced by women. Recent 
studies from the UK (Report of a Workshop, London, 1989; Waterson and Ettorre, 1989) have 
identified problems, such as, fear associated with help seeking, of embarrassment, shame, and 
most important of all fear of losing their children. Under New York state law, for example, a 
child who tests positive for drugs at birth is presumptive evidence of neglect or abuse by the 
mother. The outcome of this punitive legislation is that about 50% of such cases end up in foster 
care – more than 90% of them African-American or Hispanic (Drucker, 1990). 
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Such indifferent treatment of women indicates their powerlessness, (a possible explanation for the 
higher than expected percentage of women living with a drug using partner) in particular those 
from certain minority groups and those disadvantaged by adverse socio-economic circumstances. 
A recent Irish discussion paper on Women, Drugs and HIV (Woods, 1992 : 9-15), referred to the 
sociological concept of labelling common in studies of mental illness. The label referred to here 
was deviance or how society viewed women’s drug use as somehow less acceptable than men’s 
use, though both would be labelled as deviant. The consequent marginalisation of women 
reinforces their isolation and findings from another study (Hedrich, 1990) suggest that women’s 
cessation of drugs was strongly related to her social relationships and emotional support from 
other people. 
Education 
The mean school leaving age for respondents in this study was 14.7 years, which meant that 44% 
left before the official age of 15 years, women proportionally more so than men. In 1988, 22% of 
persons ceased full-time education under 15 years in the greater Dublin area; the percentage in 
this study, as noted was double that. The effect of dropping out of school or early school leaving 
has well documented adverse consequences on a person’s chances of employment, and personal 
development. A variety of government and non-governmental agencies have developed 
programmes, including drug prevention ones, in an attempt to diminish or bridge the deficit 
caused by an inadequate education background. It is appropriate here to outline some of the best 
known approaches to acknowledge the recognition of this problem, and to stress the importance 
of monitoring and evaluating the course and outcome of such programmes. 
 The Youth Affairs section of the Department of Education grant aid three main projects: 
− Mainline Youth work, which has an overall objective of providing information, activity, 
and stimulation to young people. Specified organisations are grant aided, most of which 
would be aware of the drug problem and provide relevant talks and discussions around the 
issue of drug misuse. 
− Community projects specifically aimed at disadvantaged young people perceived as 
detached from mainstream living, such as, those involved in crime, alcohol and drug 
misuse and non-marital pregnancies. Selected agencies carrying out this type of work 
receive grants. 
− Youth Information Centres, which provide appropriate information to meet the needs of 
young people. 
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The Youth Affairs staff of the Department of Education is very conscious of the need to evaluate 
how these various projects are meeting their objectives and have plans as to how this might be 
carried out. 
 The Green Paper on Education proposes raising the school leaving age to 16 and includes a 
special emphasis on disadvantaged youth. 
 YouthReach, is an initiative of the Department of Labour and Education. This project set 
up in 1989 focuses on young people who are typically at least six months in the labour market, 
aged between 15-18 years and who have left school without formal qualifications or training. It 
provides “two year co-ordinated and integrated training, work experience and temporary 
employment for the most marginalised and disadvantaged early school leavers” (YouthReach, a 
summary, 1989). 
 The Health Promotion Unit, Department of Health, makes available materials on the 
subject of drugs to educate targeted groups about problems in these areas. It has embarked, with 
the Department of Education, on a pilot substance abuse preventive programme in selected 
second level schools. The project is conducted by Mater Dei Counselling Centre, with funding 
from the EC. It has also initiated a pilot parenting programme in drug prevention strategies in 
conjunction with the Southern Health Board, and also supports summer schools which provide 
teachers with in service courses in the drug misuse area. 
 A variety of non-governmental agencies such as Comhairle Ie Leas Oige and Feroige an 
Oige organise programmes for the young and disadvantaged. The Catholic Social Services 
Conference has a Drug Awareness Programme (DAP) which includes a ‘Youth to Youth’ project. 
It consists of a trained team of young persons who go to schools, youth clubs etc., using peer 
group influences to prevent drug taking among Dublin youth. DAP also produced an entertaining 
video for young people showing how and why to say ‘no’ to drugs. 
Unemployment 
While data from this study are not available for clients’ longest held employment we know that 
82% of treated drug users were unemployed when they last contacted a treatment service in the 
Dublin reporting system. A more detailed analysis for this unemployed group shows that 77% 
were male and 23% female. The proportion was almost equally divided between those aged under 
and over 25, and 98% were between the ages of 15-39. Compared with data from the Live 
Register, (Labour Force Survey, 1989, personal communication CSO), we find that a much lower 
percentage, 17%, of the population aged 15-44 were unemployed in the Dublin area. 
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 Data from the European Foundation for the Improvement of Living and Working 
Conditions (Burton, Forrest and Stewart, 1989) of comparable unemployment rates for under 2 5 
year olds as of end 1988 showed Ireland and the UK with higher male than female rates 
(Luxembourg had marginally higher rates but low overall unemployment figures). This was in the 
context of a clear excess of female rates for the combined 12 Euro countries. The report 
acknowledges that young women may be regarded as less well prepared for the labour market 
than men and more socialised into regarding the family as a legitimate alternative to employment. 
However the low participation of Irish women, the lowest in Europe at 22.6% (Eurostat, 1989), 
may have a bearing on this statistic, making it easier for women (as there are fewer of them) than 
men to get particular types of employment. The UK with one of the highest female participation 
rates in the labour force has a different explanation of higher young male unemployment rates 
which may be related to marked ethnic differences in unemployment resulting in young black 
males experiencing difficulties in finding work. 
 Recent UK and Irish studies have demonstrated that unemployment is one of the key 
adverse socio-economic factors associated with drug use. This is further elaborated on in the 
following section. 
Area of Residence 
Study clients were allocated to Electoral Areas in the greater Dublin area on the basis of their 
addresses. This broad classification of residence had to be used because as yet much of the 
information supplied to us has not sufficient detail to code according to wards or DEDs. Ideally 
we would like all centres to use the Street Index (Johnson, Johnson and Lambe, 1987) currently 
used by health personnel in the Eastern Health Board area. Such detail would allow us to rate our 
information rather than use percentages as we do here. However a crude estimation of rates for 
the age group 15-39 shows the south inner city with the highest rate, a gradient similar to 
percentages shown for the other areas (see p. 18) and a much lower overall rate for remaining 
electoral areas in the catchment area. When, hopefully, more detail regarding area of residence 
becomes available it would not be for general publication, for reasons already given, but rather 
for distribution to institutions or persons who could make constructive use of these data. 
 Our findings show that 31% of the study population reside in either the north or south inner 
city areas, characterised by high levels of unemployment, poor housing and lack of leadership. 
There is also a well documented history of drug misuse in these areas (Dean, Bradshaw and 
Lavelle, 1983; O’Kelly, Bury, Cullen et al, 1988). Other areas with high levels of treated drug 
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misuse are Ballyfermot and Drumcondra, including Ballymun, representing 13% and 11% of the 
study population respectively where adverse socio-economic conditions are also known to exist. 
 Findings from studies in the UK in the mid to late 1980s, such as those in the Wirral and 
Glasgow area, stopped short of attributing causal effects to such conditions in the case of 
devastating problem drug use. To illustrate the basis of such conclusions, the investigators of drug 
misuse in the Wirral devised nine indicators of social deprivation, using census data. They 
demonstrated consistent, significant, and positive correlations between the rates of known opiate 
use and six of the socio-economic indicator rates: unemployment, council tenancies, 
overcrowding, larger numbers of children, unskilled work force, and single parents (Parker, Bakx 
and Newcombe, 1986: 88-94). 
Primary Drug of Misuse 
An opiate was the primary drug for the majority of treated cases; 86% in the census category, and 
61% of first contacts. This preference for an opiate as a primary drug of misuse is generally in 
line with that experienced in other European countries. The mean age when misuse of primary 
drug began for respondents of this study was 19, a similar age for those who first injected their 
drugs. There is concern in Dublin regarding the increased number of intravenous drug users 
abusing prescribed opiates, notably morphine sulphate, buprenorphine and methadone 
(O’Connor, 1992). Comparable data from treatment centres in European cities for variables 
analysed in this study will be available shortly from the Pompidou Group, thus affording an 
interesting basis for comparison between the various cities. 
 Cannabis is probably the most widely misused drug in Ireland, but few users present for 
treatment. One quarter of Dublin first contacts reported cannabis as their primary drug mainly 
from centres treating school going clients, compared with 6% of census clients. This raises the 
question of whether cannabis is a gateway drug for the neophyte, who once initiated into the drug 
culture goes on to sample the more addictive hard drugs. Alternatively one could speculate that a 
proportion of cannabis users discontinue the habit and no longer remain in the system to be 
replaced by a new wave of users in the subsequent year. 
 Cannabis use in Britain is largely associated with a young age group with evidence to 
suggest that most of these young adults will have only used cannabis (The ISDD Report on Drug 
Misuse in Britain, 1991). Here in Dublin, albeit for a school going group (12-18), the reported 
lifetime prevalence rate was 22% for illicit drugs with marijuana, followed by glue or other 
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inhalants, as the most popular drugs. While lifetime use of marijuana increased with age, use of 
solvents decreased among the oldest age group (Grube and Morgan, 1986). The debate on 
possible adverse effects of cannabis has been ongoing since the Indian Hemp Drugs Commission 
investigation of 100 years ago. The overwhelming consensus from international official enquiries 
is that moderate use of cannabis carries little if any health risk (Royal College of Psychiatrists, 
1987). While accepting that the dangers of moderate use of cannabis had been exaggerated a 
dispassionate evaluation of what is known and not known at present about the drug does not 
recommend its legalisation. 
Injecting Practices 
Because such a high proportion of study clients misused opiates a correspondingly high 
percentage acknowledged having ever injected their drugs at 80%. The habit of injecting opiates 
has been almost indigenous among Dublin users, compared to opiate addicts in the UK where a 
high proportion have always smoked the drug (Hartnoll, Avico, Ingold et al, 1989). 
 Eighty six per cent of the census group had ever injected their drugs in contrast to less than 
60% of first contacts. All clients reported a decline in current injecting practices. 
Currently Sharing Practices 
Of those who had ever injected their drugs the majority had also shared. This contrasted markedly 
with those who stated that they were currently sharing, for instance 26% of census clients and 
17% of first contacts. 
 Data on the sharing of injecting equipment must be viewed with caution. Given the 
increasing disapproval that is associated with sharing there are strong psychological reasons to 
suppose that clients may have underreported the extent to which they share. Notwithstanding, a 
similar decrease has also been observed among attenders of the methadone programme and 
regular attenders of the needle exchange at the AIDS Resource Centre in Dublin (Pomeroy, 
O’Connor, and Barry, 1991; Scully, Pomeroy, Johnson et al, 1991). A sharp drop in the 
prevalence of drug-related Hepatitis B cases in the Dublin area tends to confirm this trend. 
 This drop in reported needle sharing among intravenous drug users has likewise been noted 
in the UK (Donoghoe, 1991; Klee, Faugier, Hayes et al, 1991; Martin, Serpelloni, Galvan et al, 
1990; Power, Hartnoll and Daviaud, 1988) and France (Ingold, Ingold and  Toussiat, 1991). A 
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study of risk factors for HIV-1 infection in Vienna (Loimer, Werner, and Presslich, 1991) made 
the same observation. 
 Despite encouraging observations regarding the decline in current sharing practices among 
intravenous drug users there is need to monitor the stability of these changes over longer periods 
of time as well as developing strategies for reaching those injecting drug users (IDU) not in 
treatment. There is also reason to believe that the present number of IDU who are HIV positive is 
higher than the official figure (Dean, Lavelle, O’Kelly et a\, 1992). Injecting drug use plays a 
significant role in the development of AIDS in Ireland. Data from AIDS surveillance in Europe 
(WHO-EC Collaborating Centre on AIDS, 1992) show that only three European countries, Italy, 
Spain and Yugoslavia had a higher percentage of drug-related AIDS cases than Ireland out of 31 
participating centres, by the end of December 1991. Up to the same date 1,156 persons had tested 
positive for the HIV antibody in Ireland of whom 54% were IDU. (National AIDS Strategy 
Committee, 1992). 
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Chapter 5 
Conclusions 
The findings from this study confirm much of what is already known about problem drug 
use in Dublin. Since the late 1970s the use of opiates in preference to other drugs of 
addiction has been well documented, as has the association of high levels of 
unemployment with this drug taking group. Misusers tend to be young males who live in 
those areas of the city linked with poverty in the sense of inadequate financial resources to 
cope with consumer demands, and also with the poverty of their physical environment. In 
Dublin these are areas which have been neglected by officialdom in terms of housing and 
amenities appropriate for community living. Concomitant with this is a high level of 
vandalism and movement out of such districts resulting in a loss of identification and sense 
of community among people who continue to live there. 
 New insights from this study include an estimate of the number and rate for one year 
treated prevalence of drug misuse in the greater Dublin area and the same for one year 
treated incidence. The prevalence count gives a measure of the extent of the drug taking 
phenomenon while the incidence can be seen as a benchmark against which to measure a 
future increase or decrease. 
 Study findings indicate the relatively young age of drug users here vis a vis most of 
their European counterparts, although in 1990 terms Dublin drug users are older than they 
were 10 years ago. A high percentage live with their family of origin. It must be assumed 
that many are ill prepared for employment as 44% had left school before the official school 
leaving age of 15. This figure goes some way in explaining the high percentage of 
unemployed in the study. 
 Interesting gender differences emerged from the results which highlight different 
patterns of treatment use by men and women. Despite an increasing proportion of women 
now coming for treatment they are older when they present for the first time than men. 
Women are more likely than men to be living with a drug misusing partner. This appears to 
be the case in other cultures and linked with women’s relative lack of power and economic 
control in society generally. Another worrying feature is that of those users in Dublin who 
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were currently injecting their drugs a higher proportion of women than expected were 
currently sharing. 
 While there is encouraging news in the current decline of injecting and sharing 
practices, noted also in other European cities, it must be stressed that drug-related AIDS 
cases in Ireland are considerably higher than most European countries. This demands 
ongoing efforts to encourage users to alter their intravenous route of administering opiates 
to less lethal ways. 
 Research findings are of no value in a problem context like drug misuse, unless 
acted upon. Our data show that drug takers presenting for treatment are characterised by 
disadvantage and youth. We suggest that the situation could be more effectively tackled if 
viewed primarily as a social problem with an element of psychopathology. 
Acknowledgement of some of these social deficits have been noted in recent government 
policy documents. The Government Strategy to Prevent Drug Misuse Report and the more 
recent one from the National AIDS Strategy Committee (1992) acknowledge the 
problematic social background of drug users. The AIDS strategy report (p. 12) states that 
all the indications are that the majority of people affected (by HIV) at present are 
from the deprived urban areas and many have experienced social and economic 
disadvantage unrelated to HIV and AIDS. 
One of the key objectives to emerge from the Government Strategy to Prevent Drug 
Misuse was the establishment of a national drug misuse database, similar to that in 
operation in the greater Dublin area. This is now being implemented and will provide 
factual data to inform future action in this problem area. As drug misuse is an 
acknowledged problem in all European countries, national databases can facilitate an 
understanding of the epidemiology of drug misuse, its social and health care implications 
and the effect of prevention and treatment programmes. The standardisation of data 
collection at European level by the epidemiology group of the Council of Europe, 
Pompidou Group, greatly enhances the interpretation, monitoring and evaluation of such 
data. 
 The Government Strategy Report referred to above emphasises the importance of 
comprehensive demand reduction policies covering areas of education, treatment and 
rehabilitation. Education has a crucial role to play in primary prevention and a range of 
health, education and labour based projects have been outlined earlier. Common sense 
suggests the importance of evaluating such existing programmes (and indeed such 
interventions are planned in certain projects) rather than let them operate uncritically 
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without some check on their use and value. Outcome evaluation of the impact of school-
based drug education in Scotland (Coggans, Shewan, Henderson et al, 1991) revealed that 
the effect of the programme was to make young people more knowledgeable about drugs 
rather than prevent their misuse of them. It has more recently been suggested that health 
education works cumulatively by repeated exposure to the same message presented in 
different ways over a period of years, rather than as once-off campaigns (Sutton, 1992). 
 The proposed extension of the school leaving age in Ireland to 16 appears irrelevant 
to Dublin drug users when as seen from this study, a high proportion leave school before 
the present leaving age of 15. Rather the reference in the Green Paper to make people more 
employable is the direction appropriate for the disadvantaged. 
 The Government’s approach is clearly one of pragmatism when commenting on the 
range of existing treatment and rehabilitation services in its strategy report (p. 16) as 
follows, 
of its nature, the treatment, care and management of the drug misuser does not lend 
itself to any ‘one solution approach’. The Government accepts that the provision of 
services aimed at the achievement of a drug-free society only or harm reduction 
programmes solely are inappropriate. 
In conclusion two recommendations are outlined for consideration; firstly, that some 
specific approach should be found of using the findings from this study in ameliorating 
problem drug use in Dublin. Secondly, suggested areas are noted for further data collection 
and research. 
 One of the measures proposed by the Government in its strategy on drug misuse (see 
pp. 18 and 19 of the report) is the development of Community Drug Teams (CDT) under 
the auspices of the health boards to operate with the involvement of general practitioners 
and other health professionals in targeted areas. The role of these CDT covers: the 
identification of the extent of drug misuse through contact with known drug users and 
persons at risk; on going monitoring of drug misusers following treatment and the 
establishment of links with appropriate statutory and voluntary treatment services. 
 The role and structure of CDT provide an ideal context for addressing the findings 
of this study. Our proposed approach is the appointment of a small team to undertake 
action research in one of the CDT’s areas of operation. The suggested focus of study is 
− unemployed drug misusers and 
− the special needs of women drug takers. 
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The CDT would have access to a range of professional expertise from both statutory and 
voluntary agencies and could tap into additional information on, for example, health 
promotion and women’s studies. Strategies to reduce the drug taking practices of the two 
targeted groups would be developed, tried, altered as appropriate, and progress reported on. 
Successful measures from this pilot study could then be implemented in other areas of 
Dublin. 
 The focus of this report has been persons in receipt of treatment for their drug 
misuse. Information from other indicators of problem drug activity, such as, persons 
charged for drug offences, seizures of illicit drugs, price and purity of drugs, and drug-
related Hepatitis B, has already been collated for the Dublin area for the past 10 years and 
will be available shortly. These data will give a more comprehensive insight into problem 
drug use. In addition, collaborative work at European level will provide a context for such 
data as well as access to drug trends in Europe and interpretation of changes that may 
occur. 
 Having established the treated number and rate for drug misuse we are now at the 
stage to progress further. Several approaches are open to gaining information on the ‘true’ 
prevalence of drug taking. These include a household survey in association with special 
surveys of high risk groups not easily accessible such as, the ‘travellers’, the homeless, 
early school drop outs and highly mobile sections of the population. Other methods include 
statistical projections based on death rates of drug users, or the capture/recapture technique 
using information from independent sources of problem drug use. The snowball approach 
has been used successfully in many European projects involving a chain referral type of 
sampling within drug-using networks. 
 Based on information available to us in Dublin on treated drug use it is now time to 
undertake qualitative ethnographic research. This approach could provide more sensitive 
information on e.g., drug users’ social networks, their perceptions of different drugs, and 
unemployment. It would, in addition, be an ideal follow-up to understanding some of the 
findings from this study, notably why proportionally more women than men live with a 
drug misusing partner and also currently share their injecting equipment. 
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APPENDIX A 
Frequency Tables 
Frequency Tables 
 TREATED
PREVALENCE 
CENSUS FIRST
CONTACT 
Table A1 
Type of Contact 
N % N % N % 
new client 1022 50.2 98 21.2 589 94.4 
old client 1005 49.3 364 78.8 33 5.3 
n/k 10 0.5 – – 2 0.3 
Table A2 
Ever Previously 
Treated 
never 698 34.3 74 16.0 624 100.0 
previously treated 1300 63.8 384 83.1 – – 
n/k 39 1.9 4 0.9 – – 
Table A3 
In Contact with 
Other Centres 
     
no 1233 60.5 292 63.2 473 75.8 
yes 749 36.8 168 36.4 131 21.0 
n/k 55 2.7 2 0.4 20 3.2 
Table A4 
Sex 
      
male 1501 73.7 304 65.8 466 74.7 
female 536 26.3 158 34.2 158 25.3 
Table A5 
Age 
      
< 25 years 980 48.1 197 42.6 425 68.1 
25 + years 1013 49.7 257 55.6 191 30.6 
n/k 44 2.2 8 1.7 8 1.3 
Table A6 
Living Status 
      
alone 201 9.9 52 11.3 73 11.7 
with family 1006 49.4 181 39.2 375 60.1 
with friends 50 2.5 6 1.3 22 3.5 
partner, drug misuser 253 12.4 66 14.3 46 7.4 
partner, not drug misuser 266 13.1 70 15.2 60 9.6 
institution 54 2.7 40 8.7 9 1.4 
homeless/transient 53 2.6 7 1.5 18 2.9 
other 84 4.1 32 6.9 10 1.6 
n/k 70 3.4 8 1.7 11 1.8 
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     Table A7 
Employment Status      
regular work 199 9.8 33 7.1 68 10.9 
unemployed 1640 80.5 381 82.5 474 76.0 
student 62 3.0 11 2.4 44 7.1 
housewife 75 3.7 22 4.8 13 2.1 
other 29 1.4 6 1.3 18 2.9 
n/k 32 1.6 9 1.9 7 1.1 
     Table A8 
Age Left School      
< 15 years 696 34.2 197 42.6 167 26.8 
15 + years 896 44.0 203 43.9 283 45.4 
n/a 51 2.5 8 1.7 37 5.9 
n/k 394 19.3 54 11.7 137 22.0 
     Table A9 
Level Reached      
primary 404 19.8 125 27.1 72 11.5 
secondary 811 39.8 182 39.4 258 41.3 
third level 16 0.8 4 0.9 5 0.8 
n/a 51 2.5 8 1.7 37 5.9 
n/k 755 37.1 143 31.0 252 40.4 
     Table A10 
Primary Drug of Misuse      
opiates/opioids 1613 79.2 395 85.5 376 60.3 
stimulants 23 1.1 4 0.9 10 1.6 
hypnotics/sedatives 74 3.6 15 3.2 36 5.8 
hallucinogens 9 0.4 2 0.4 5 0.8 
volatile inhalants 49 2.4 11 2.4 29 4.6 
cannabis 233 11.4 28 6.1 156 25.0 
other 18 0.9 5 1.1 7 1.1 
n/a 2 0.1 – –2 0.3  
n/k 16 0.8 2 0.4 3 0.5 
     Table All 
Age First Used      
< 20 years 1263 62.0 298 64.5 423 67.8 
20 + years 637 31.3 146 31.6 161 25.8 
n/a 2 0.1 2 0.3   
n/k 135 6.6 18 3.9 38 6.1 
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      Table A12 
Frequency Past Month       
drug free 370 18.2 152 32.9 90 14.4 
< once weekly 97 4.8 14 3.0 34 5.4 
once weekly 47 2.3 6 1.3 20 3.2 
twice + weekly 142 7.0 33 7.1 62 9.9 
daily 618 30.3 50 10.8 225 36.1 
twice + daily 653 32.1 192 41.6 161 25.8 
n/k 110 5.4 15 3.2 32 5.1 
      Table A13 
Route       
inject 1289 63.3 305 66.0 290 46.5 
smoke 273 13.4 37 8.0 166 26.6 
eat/drink 263 12.9 57 12.3 102 16.3 
sniff 77 3.8 21 4.5 41 6.6 
n/a 2 0.1 – – 2 0.3 
n/k 133 6.5 42 9.1 23 3.7 
      Table A14 
Duration in Years       
< 5 years 886 43.5 162 35.1 385 61.7 
5 – 9 years 610 29.9 164 35.5 137 22.0 
10 + years 317 15.6 105 22.7 51 8.2 
n/a 2 0.1 – – 2 0.3 
n/k 222 10.9 31 6.7 49 7.9 
     Table A15 
Secondary Drug of Misuse       
opiates/opioids 1014 49.8 246 53.2 239 38.3 
stimulants 38 1.9 17 3.7 14 2.2 
hynotics/sedatives 91 4.5 14 3.0 35 5.6 
hallucinogens 19 0.9 2 0.4 12 1.9 
volatile inhalants 8 0.4 1 0.2 6 1.0 
cannabis 235 11.5 41 8.9 82 13.1 
alcohol 215 10.6 64 13.9 94 15.1 
other 21 1.0 3 0.6 12 1.9 
n/a 362 17.8 53 11.5 126 20.2 
n/k 34 1.7 21 4.5 4 0.6 
      Table A16 
Age First Used       
< 20 years 975 47.9 256 55.4 307 49.2 
20 + years 477 23.4 104 22.5 123 19.7 
n/a 362 17.8 53 11.5 126 20.2 
n/k 223 10.9 49 10.6 68 10.9 
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      Table A17 
Frequency Past Month       
drug free 237 11.6 96 20.8 57 9.1 
< once weekly 152 7.5 34 7.4 50 8.0 
once weekly 95 4.7 21 4.5 28 4.5 
twice + weekly 346 17.0 138 29.9 96 15.4 
daily 473 23.2 39 8.4 161 25.8 
twice + daily 173 8.5 33 7.1 50 8.0 
n/a 362 17.8 53 11.5 126 20.2 
n/k 199 9.8 48 10.4 56 9.0 
      Table A18 
Route       
inject 639 31.4 173 37.4 141 22.6 
smoke 243 11.9 38 8.2 83 13.3 
eat/drink 561 27.5 121 26.2 215 34.5 
sniff 28 1.4 6 1.3 13 2.1 
n/a 362 17.8 53 11.5 126 20.2 
n/k 204 10.0 71 15.4 46 7.4 
      Table A19 
Duration in Years       
< 5 years 692 34.0 131 28.4 285 45.7 
5-9 years 449 22.0 135 29.2 85 13.6 
10+years 241 11.8 83 18.0 42 6.7 
n/a 362 17.8 53 11.5 126 20.2 
n/k 293 14.4 60 13.0 86 13.8 
      Table A20 
Ever Injected       
yes 1590 78.1 389 84.2 355 56.9 
no 394 19.3 64 13.9 248 39.7 
n/k 53 2.6 9 1.9 21 3.4 
      Table A21 
Age First Injected       
< 25 years 1179 57.9 322 69.7 281 45.0 
25 + years 100 4.9 20 4.3 20 3.2 
n/a 394 19.3 64 13.9 248 39.7 
n/k 364 17.9 56 12.1 75 12.0 
      Table A22 
Currently injecting       
yes 991 48.6 206 44.6 223 35.7 
no 543 26.7 179 38.7 105 16.8 
n/a 394 19.3 64 13.9 248 39.7 
n/k 109 5.4 13 2.8 48 7.7 
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      Table A23 
Ever Shared       
yes 1239 60.8 332 71.9 228 36.5 
no 237 11.6 32 6.9 101 16.2 
n/a 394 19.3 64 13.9 248 39.7 
n/k 167 8.2 34 7.4 47 7.5 
      Table A24 
Currently Sharing       
yes 245 12.0 93 20.1 52 8.3 
no 1189 58.4 273 59.1 254 40.7 
n/a 394 19.3 64 13.9 248 39.7 
n/k 209 10.3 32 6.9 70 11.2 
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APPENDIX B 
Population of the Greater Dublin Area 
1981 and 1986 
Age and Sex 
Numbers 
 1981 1986 
Age Male Female Total Male Female Total 
>15 133,948 127,618 261,566 124,308 117,674 241,982 
15-19 47,469 49,682 97,151 46,232 46,039 92,271 
20-29 78,282 84,491 162,773 82,541 88,414 170,955 
30-39 55,740 58,092 113,832 59,702 63,715 123,417 
40-49 42,863 46,002 88,865 45,474 48,637 94,111 
50+ 79,736 111,192 190,928 83,828 114,392 198,220 
Total 438,038 477,077 915,115 442,085 478,871 920,956 
Source: Ireland, Census 1981 and 1986, Central Statistics Office. 
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APPENDIX C 
Dublin Drug Reporting System 
Treatment Centres 
The Drug Treatment Centre Board 
(formerly the National Drug Advisory and Treatment Centre). 
− A statutory out-patient counselling, prescribing (methadone) and detoxification service, 
with 10 beds in Beaumount Hospital. 
Coolemine Therapeutic Community 
− A voluntary non-prescribing agency providing counselling and support at induction, day 
programme, residential and after care level. 
The Rutland Centre 
− A voluntary non-prescribing agency providing counselling and therapy at residential and 
day care level. 
The Ana Liffey Drug Project 
− A voluntary non-prescribing street agency offering counselling and support at day care 
level. 
The Addiction Counsellors 
− A statutory non-prescribing service operated in the Dublin Community Care areas by eight 
professional workers in 1990 from various health centres offering counselling and support 
at day care level. 
Ballymun Youth Action Project 
− A voluntary non-prescribing community based agency offering individual counselling, 
group work, family counselling and a range of social activities. 
General Practitioner 
− A non-prescribing, counselling and support service offered by a general practitioner. 
Benzodiazepines have occasionally been used to detoxify patients. 
St. Patrick’s Hospital 
− A service offered by psychiatrists in a private facility at in- or out-patient level. 
St. John of God Hospital 
A service offered by psychiatrists in a private facility at in-or out-patient level. 
Mountjoy Prison 
− A detoxification, counselling and support service. 
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St. Patrick’s Institution 
− A detoxification, counselling and support service. Arbour Hill Prison A detoxification, 
counselling and support service. 
Probation Service, Smithfield 
− A statutory counselling and support service for clients on probation. 
Talbot Day Centre 
− A statutory community-based programme for drug free youth providing remedial 
education, individual and group counselling. Group therapy is also available for family 
members. 
Mater Dei Counselling Centre 
− A voluntary specialised counselling unit for adolescents, providing out-patient services, 
such as, individual counselling, family therapy and drama group. 
Mater Child Guidance Clinic 
− A statutory agency providing out-patient services, for example, counselling and therapy. 
Ushers Island Clinic and Day Centre 
− A statutory agency providing assessment and treatment for disturbed adolescents on an 
out-patient basis. 
Wheatfield Prison 
− A detoxification, counselling and support service. 
Candle Community Trust 
− A community based centre for drug free young men providing day, personal development 
and training workshop facilities. 
Merchant’s Quay Project 
− A voluntary service providing counselling and advice to drug users affected by HIV and 
also referral to other agencies. 
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APPENDIX D 
Draft Core Data For Drug Treatment 
Reporting System 
POMPIDOU-EC PROJECT 
(Complete Boxes, write information and circle codes as appropriate) 
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Instructions for Completion of Form 
(to be completed once for each client for the period under review) 
1. City or Health Board Area 
Enter appropriate code which will be provided. 
2. Treatment Centre 
Enter treatment centre code which will be provided. 
3. Client Number 
This should be a number which uniquely identifies the client. The first two digits will be 
the treatment centre code, the third digit the specialist code, where one exists within the 
centre, otherwise a zero will be used. The remaining five digits relate directly to the client 
and will be computer generated or supplied by the centre. 
4. Date 
This refers to the date on which the client makes contact with the centre. The first two 
digits refer to the day, the second two to the month and the last two to the year. Where day 
or month is represented by one digit, this digit should be entered in the second box of day 
or month, and a zero entered in the preceding box of day or month. 
5. Type of Contact with This Centre 
Circle the relevant code. New client is a client making a first contact with the treatment 
centre, old client is a client making a second or subsequent contact. It should be possible in 
all cases to distinguish between new and old clients and code accordingly, however code 9 
is provided when this information is not known. 
6. Ever Previously Treated 
Circle the relevant code. Never, refers to a client who has never had a drug-related 
treatment contact anywhere for drug misuse and is therefore making a first ever treatment 
contact. Previously treated, refers to a client who has already made contact either with the 
centre for which information is being completed or who has had any other drug treatment 
contact elsewhere. This is a crucial question and it is essential that accurate information be 
obtained. (Please note that where a client is recorded as ‘never previously treated’ he/she 
cannot be coded as ‘old client’ in Q.5, nor as ‘currently in contact with other centres’ in 
Q.7.) 
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7. Currently in Contact with other Centres – for a drug problem 
a) Circle the relevant code. No, refers to a client who has not been in contact with 
another drug treatment centre(s) in the 30 days prior to the current contact. Yes, 
relates to a client who is or has been in contact with another centre(s) in the 30 days 
prior to the start of this treatment contact. It should be possible in all cases to 
establish whether a client is currently in contact with other centre(s) or not; however, 
code 9 is provided when this information is not known. 
b) Where a current contact with other centre(s) has been ascertained and code 2 in the 
a) part of the question is circled then the name(s) of the other centre(s) should be 
recorded. 
8. Sex 
Circle the appropriate code. 
9. Age 
Record the client’s age in years at time of contact with the centre in the boxes provided. 
10. Living Status 
Circle the relevant code, and specify where necessary. Living status refers to current living 
status. Code 2, with family, refers to living with family of origin. Codes 4 and 5 relating to 
partner – drug misuser/not drug misuser, may refer to a spouse or to a male/female partner 
lived with. 
11. Area of Residence 
Record the current area of residence by using the codes in the EIS street index. 
12. Ethnicity 
Circle relevant code and specify where necessary. 
13. Employment Status 
Record current employment status by circling the relevant code and specifying where 
necessary. 
14. Education 
a) Record age in years when left full time education in boxes provided. 
b) Record the highest educational level reached. Government sponsored work schemes 
are not regarded as educational schemes and therefore should not be recorded here. 
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15. Problem Drug Use (refers to the month before presenting for treatment) 
Primary 
Record the drug name which the client alleges at the time of current treatment contact is 
causing most problems and for which treatment is sought. 
Alcohol may not be recorded as a primary drug of misuse and clients whose primary drug 
of misuse is alcohol should be excluded from the system. 
Secondary 
Where the client is misusing a second drug in addition to the primary one specified record 
the name. If none, write none. 
Alcohol may be recorded as a secondary drug of misuse. 
Age First Used 
Record age in years for the drug recorded. 
Frequency Past Month (prior to current treatment contact) Record the relevant code for 
the drug recorded in the space provided from the list supplied. 
Route 
Record the relevant code for the drug recorded in the space provided from the list supplied. 
Duration in Years 
Record the number of years for which the drug recorded has been actively misused. Six 
months to less than 12 months misuse should be recorded as one year. Less than six 
months misuse should be recorded as 0. 
16. Ever Injected 
a) Circle the relevant code. Injection refers to inserting a needle into a vein, muscle 
tissue, or under the skin. 
b) Record age in years when first injected. (Please note that if ‘no’ is recorded for this 
question then Q.I 7, 18 and 19 are not applicable). 
17. Currently Injecting 
Circle the relevant code. 
Injection refers to inserting a needle into a vein, muscle tissue, or under the skin. 
18. Ever Shared 
Circle the relevant code. 
19. Currently Sharing 
Circle the relevant code. 
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Drug Classification 
1. OPIATES AND OPIOIDS 
Buprenorphine 01 
Codeine (linctus) 02 
Dextromoramide 03 
Dextropropoxyphene 04 
Dihydrocodeine 05 
Dipipanone 06 
Heroin 07 
Methadone 08 
Morphine 09 
(including Morphine Sulphate 
Tablets – MST) 
Opium 10 
Pentazocine 11 
Pethidine 12 
Other opiates/opioid 88 
2. STIMULANTS 
Amphetamine 01 
Dexamphetamine 02 
Methamphetamine 03 
Methylphenidate 04 
Other amphetamine 
like drugs 05 
Cocaine 06 
Crack 07 
Other cocaine forms 08 
3. HYPNOTICS AND 
SEDATITIVES 
Barbiturates 01 
Chlordiazepoxide 02 
Diazepam 03 
Flurazepam 04 
Lorazepam 05 
Oxazepam 06 
Nitrazepam 07 
Temazepam 08 
Triazolam 09 
Other minor 
Tranquillizers 10 
Major tranquillizers 11 
Other hypnotics and 
Sedatives 88 
4. HALLUCINOGENS 
Lysergic Acid Diethylamide 01 
Amanita Muscaria 02 
Psilocybin 03 
Phencyclidine 04 
MDMA (Ecstasy) 05 
MDA 06 
Other hallucinogens 88 
5. VOLATILE INHALANTS 
Glue 01 
Butane 02 
Other solvents 03 
Petrol 04 
Nitrites 05 
Other volatile inhalants 88 
6. CANNABIS 
Herbal 01 
Resin 02 
Oil 03 
Other cannabis forms 88 
7. ALCOHOL 
8. OTHER DRUGS 
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